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CHAPTER 1 
GENERAL INTRODUCTION 
Thesis organization 
The following thesis is organized into 4 chapters and 2 appendices. Chapter 1 is a 
review of literature in the area of coronavirus and its effects on intestinal morphology and 
function in neonatal calves. It also reviews acid-base balance and vitamins A, E and C as 
well as growth factors IGF-I, TGF-Pl and TGF-P2. Chapter 2 is a summary of research 
conducted to determine effects of the addition of vitamins A and E or concentrated protein 
serum fraction to electrolytes on intestinal recovery from coronavirus challenge in calves. 
Chapter 3 is a summary of research conducted to determine effects of infusing glucose and 
electrolytes into the rumen of calves on feed intake, gain, and feed efficiency. Chapter 4 
consists of general conclusions. Appendix A contains methodology of xylose and 
haptoglobin analyses. Appendix B describes vitamin A, E, and C functions as well as 
vitamin interactions. Research summarized in this thesis will ultimately be submitted for 
publication and co-authors will include H. D. Tyler and J. D. Quigley, III, M.L. O'Brien, K.J. 
Touchette, JA Coalson 
Effects of oral rehydration solutions in neonates challenged with bovine 
coronavirus: A review 
Introduction 
Coronavirus is one of the most common causes of calf diarrhea. Infection with 
coronavirus disrupts absorption of electrolytes by enterocytes, causing sloughing of the 
intestinal lining. This alters electrolyte balance, thus affecting acid-base balance in the body. 
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Current oral rehydration solutions restore acid-base balance, but with the addition of specific 
vitamins or growth factors, they may restore enterocyte function and maintain the primary 
defense against pathogens. This review focuses primarily on coronavirus and its effects on 
acid-base balance and intestinal morphology, as well as effects of supplementation of 
vitamins A and E or growth factors to oral rehydration solutions. 
Causes of enteric disease 
Neonatal calf diarrhea is a major cause of death and economic loss in the dairy 
industry. Treatment of scouring calves is not only expensive, but it is also often difficult 
because of the numerous causative pathogens and the difficulty in diagnoses (Constable et 
al., 1996; Torres-Medina et al., 1985). 
Enteric bacteria most commonly disrupt the absorptive and secretory mechanisms of 
the intestinal tract. For example, Cryptosporidium palilum causes inflammation by attaching 
to the epithelial cells and decreasing absorption. Escherichia coli secretes bacterial 
enterotoxins, disturbing the secretion and absorption of ions through the villi (Nappert et al., 
2000; Torres-Medina et al., 1985). Salmonella produces enterotoxins, causing inflammation 
and intestinal disturbance of glucose-linked sodium absorption. Coronavirus infection results 
in the replacement of mature epithelial cells with immature cells, disrupting absorption 
(Torres-Medina et al., 1985). Coronavirus is one of the most common pathogens that causes 
calf scours, along with cryptosporidium and rotavirus (McDonough et al., 1994); anywhere 
from 15 to 70% of diarrheal outbreaks in calves may be due to coronavirus (Crouch et al., 
1985). 
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Coronavirus 
Coronavirus was named after its resemblance to the solar corona (Sharpee et al., 
1976). It is a pneumoenteric virus in the Coronaviridae family of RNA viruses, infecting 
both the respiratory tract as well as the gastrointestinal tract (Saif et al., 1986; Sharpee et al., 
1976; Torres-Medina et al., 1985). It is widely distributed and affects many species, 
including human, cattle, mice, pigs, rats, dogs, chickens, turkeys, and maybe even foals 
(Sharpee et al., 1976). Most calves are infected with bovine coronavirus (BCV) between 5 
and 20 d of age, but adult cattle can also be infected (Kapil et al., 1990; Torres-Medina et al., 
1985). 
The virus infects the cytoplasm of cells (not the nuclei) and replicates in epithelial 
cells of the respiratory and gastrointestinal tracts (Kapil et al., 1990; Pensaert and Callebaut, 
1994; Sharpee et al., 1976). It replicates in enterocytes of the small intestine as well as the 
colonic villous and crypt epithelium (Hoblet et al., 1992; Kapil et al., 1990; Pensaert and 
Callebaut, 1994). This can be demonstrated experimentally by injecting fluorescence-labeled 
coronavirus antisera to directly display the location of virions in the intestinal tract. Tips of 
the villi and villous cells fluoresce in the both jejunum and ileum, indicating attachment of 
coronavirus in the distal part of the small intestine (Bridger et al., 1978). Mebus (1975) also 
reported immunofluorescence in the villous epithelium of the duodenum. 
Six properties characterize the coronavirus group. They have petal-like surface 
structures 20 nm long, their size averages 80 nm, they replicate within cytoplasmic vesicles, 
they have an essential lipid envelope (that makes them sensitive to temperature), they have 
low particle density, and they use ribonucleic acid to replicate (since inhibiting their DNA 
metabolism does not prevent replication). Enteric coronaviruses are acid stable at a pH as 
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low as 3.0, enabling them to safely pass through the stomach into the intestinal tract. 
Conversely, respiratory coronaviruses are acid labile, and are more dramatically affected by 
fluctuations in acidity (Sharpee et al., 1976). 
Coronaviruses are able to infect other cells due to their surface glycoproteins. These 
glycoproteins interact with host cell membrane receptors and fuse the viral envelope of the 
coronavirus with the plasma envelope of host cells (Holmes and Williams, 1990). All 
coronaviruses contain the membrane glycoproteins Mand Sand some, especially BCV, 
contain the membrane glycoprotein HE (Holmes and Williams, 1990; Kienzle et al., 1990; 
Vlasak et al., 1988). 
The HE glycoprotein enables BCV to infect many hosts and have an altered 
pathogenicity (Holmes and Williams, 1990). It enables the virus to enter the cell by 
destroying cell receptors that would prevent entry under normal circumstances. The HE 
glycoproteins that are not incorporated into virions migrate to cell surfaces and adsorb to 
erythrocytes causing hemagglutination (Clark, 1993; Holmes and Williams, 1990; Kienzle et 
al., 1990; Vlasak et al., 1988). 
The M glycoprotein determines the site of virus budding in host cells and interacts 
with the nucleocapsid. The glycoprotein S is essential for infectivity and ensures that host 
cells fuse with viral cells (Holmes and Williams, 1990; Kienzle et al., 1990; Vlasak et al., 
1988). 
Replication occurs in the cytoplasm when viral RNA attaches to ribosomes and 
translates its own viral proteins. Viral proteins replace host proteins in the golgi apparatus 
and rough endoplasmic reticulum, thus pinching off whole virions and expelling them into 
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the intestinal lumen. Few virions are released through lysis of dying cells; most are released 
from normal, living cells (Clark, 1993). 
Small intestinal morphology 
Small intestinal cells are highly differentiated and morphologically complex. The 
surface area of the small intestine is greatly amplified by longitudinal and circular concentric 
folds (Barnwal and Yadava, 1975; Trier and Madara, 1981). These folds are mainly located 
in the distal duodenum and proximal jejunum and are less visible in the ileum (Trier and 
Madara, 1981). 
The small intestine is comprised of three tissue layers; muscularis mucosa, lamina 
propria, and epithelium. The muscularis mucosa is a continuous sheet of smooth muscle 3 to 
10 cells thick that separates the mucosa from the submucosa. Contractions of the muscularis 
may add to the movement of the villi, mixing the contents of the small intestinal lumen and 
increasing absorptive function. This may also facilitate emptying of the crypt luminal 
contents by causing compression of the lumen (Trier and Madara, 1981). 
The lamina propria lies between the epithelium and the muscularis mucosa. It 
surrounds the crypt epithelium and contains cells that are important for immune function as 
well as blood vessels that provide a nutrient supply (Trier and Madara, 1981). 
The third layer is a single cell layer of epithelial cells that line the villi and the crypts. 
The crypt epithelium contains undifferentiated cells in the process of mitosis and 
proliferation. Although the villus epithelium absorbs many substances, it also secretes 
numerous substances that act to maintain homeostasis. The brush border includes long, thin 
microvilli that line columnar epithelial cells and increase the absorptive surface 7- to14-fold 
(Trier and Madara, 1981). 
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Differentiation of enterocytes occurs along the villus, starting out as undifferentiated 
cells at the crypt base and migrating into specified cell types (Leblond and Stevens, 1948; 
Sassier and Bergeron, 1978; Trier and Madara, 1981; Zile et al., 1977). The replacement of 
cells maintains a steady state in the population of epithelial cells (Sassier and Bergeron, 
1978). Dividing cells that are labeled in the crypts either migrate up the villus or remain in 
the crypts to divide again (Zile et al., 1977). 
Effects of coronavirus on intestinal functions 
Normal small intestinal villous function includes secretion of enzymes on the apical 
villous membrane that digest carbohydrates. Solutes, including sodium, chloride and 
glucose, are transported by carriers or passive diffusion through the villous cell membrane 
(Reifen et al., 1998; Torres-Medina et al., 1985). Crypt cells, which are too immature to 
either digest or absorb, secrete bicarbonate and chloride ions into the lumen of the small 
intestine, directing water movement through passive diffusion. During normal conditions, 
absorption of substances through the villi outweighs the crypt secretion, resulting in net 
absorption of water, substrates, and ions. When these enzymes or transport processes are 
negatively affected, substrates, ions and water are excreted out of the digestive tract at a 
faster rate than absorption can occur (Torres-Medina et al., 1985). 
Diseases that affect mucosal function of the intestine destroy villus architecture and 
decrease absorptive surface area of the small intestine (Bridger et al., 1978; Clark, 1993; 
Holland et al., 1992; Saif et al., 1986). Infection with coronavirus frequently causes lesions 
to appear on the intestinal surface, decreasing the villus to crypt ratio. Villi become thick and 
lined with cuboidal epithelial cells (Bridger et al., 1978; Clark, 1993; Mebus et al., 1975; 
Pensaert and Callebaut, 1994; Saif et al., 1986). Some villi become ragged at the luminal 
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surface causing the lamina propria to be exposed at the villous tips (Bridger et al., 1978; 
Mebus et al., 1975). Similarly, large intestinal cells become cuboidal and squamous and 
goblet cell numbers decrease although no defined lesions appear (Bridger et al., 1978; Clark, 
1993). 
This loss of epithelial function results in malabsorption of water, sodium, and 
chloride (Torres-Medina et al., 1985). These poorly absorbed solutes, in addition to 
undigested lactose remaining in the small intestinal lumen, can cause osmotic retention of 
fluid. This results in less absorption of solutes and further draws water from the enterocytes 
(Clark, 1993; Menzies et al., 1990). As excretion of electrolytes and fluids continues, losses 
of electrolytes from extracellular fluid (ECF) cause water to move out of the hypo-osmotic 
ECF (Constable et al., 1996; Nappert et al., 2000). Decreased intestinal absorption and 
prolonged diarrhea occur due to cells sloughing off and being replaced with immature cells 
that are unable to perform normal functions and are redirected to function only for viral 
production (Clark, 1993; Holland et al., 1992; Mebus et al., 1975). Continued diarrhea 
increases the risk of dehydration, lactic acidemia and hypoglycemia and may eventually lead 
to death (Clark, 1993; Pensaert and Callebaut, 1994). 
Although the incubation period of coronavirus is only 24 to 48 hours, clinical signs of 
the infection usually take 36-60 hours (Clark, 1993; Pensaert and Callebaut, 1994; Torres-
Medina et al., 1985). Forty to ninety hours after infection, loss of enterocytes from the small 
intestinal villi is extensive. Alteration in cellular potassium levels and hypoglycemia cause 
calves to become lethargic. Water loss decreases total circulatory fluid volume stimulating 
vasoconstriction to maintain blood pressure. Blood flow to extremities is decreased, causing 
them to cool and atrophy (Torres-Medina et al., 1985). Lack of blood flow to the tips of the 
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intestinal villi decreases absorption of ingested nutrients and impairs villous function 
(Nappert et al., 2000). Calves become depressed, anorexic and their feces may include 
mucus and milk curds. If diarrhea is not treated, calves can become too weak to stand after 
2-4 days and death may occur (Pensaert and Callebaut, 1994; Torres-Medina et al., 1985). 
Acid-base balance 
Once a calf develops diarrhea, it needs to be treated with fluid therapy either orally or 
intravenously to avoid problems such as metabolic acidosis (Booth and Naylor, 1987; 
Groutides and Michell, 1990). If rehydration therapy does not occur, mortality rate increases 
significantly (up to 80%) especially if blood pH drops below 7.2 (Booth and Naylor, 1987). 
One primary function of therapy with oral rehydration solutions (ORS) is to restore 
acid-base balance. Conventionally, this is assumed to be accomplished by affecting the 
concentration of hydrogen ions in the various fluid compartments of the body. Traditionally, 
the concentration of hydrogen ions is monitored by analyzing the pH of body fluids. The pH 
is the inverse of the concentration of hydrogen ions and the Henderson-Hasselbalch equation 
is used to describe the relationship between dissociable acids and pH: 
pH= pK + log([A-]/[HA]) 
where concentration of A- represents any anion, concentration of HA represents the 
undissociated acid, and pK represents the dissociation constant of the acid. The Henderson-
Hasselbalch equation is used to understand changes in pH when [Ir] or [Off] are changed 
(Ganong, 1999). 
The carbonic acid-bicarbonate system is a major buffer system in the body that 
regulates acid-base in blood. Bicarbonate dissociates into hydrogen ions and carbonic acid: 
HzC03 ~ W + HC03-
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In the body, bicarbonate and carbonic acid also equilibrate with dissolved carbon dioxide: 
H2C03 +-+ C02 + H20 
This buffer system is easily regulated as dissolved carbon dioxide concentrations are 
regulated by respiration and plasma [HC03-] is conventionally assumed to be regulated by 
the kidneys. The enzyme that regulates the dissociation of bicarbonate is carbonic 
anhydrase. When activated, carbonic anhydrase increases the conversion of bicarbonate to 
water and carbon dioxide, helping to regulate blood acid-base balance (Ganong, 1999). 
This conventional paradigm of acid-base balance is disputed by Stewart (1981). 
Instead of looking at pH in the entire body, Stewart (1981) focuses on individual systems in 
the body and how specific variables act to affect acid-base balance. 
Stewart (1981) describes two types of variables that exist in all systems of the body 
and influence acid-base balance. The first are independent variables that are controlled from 
outside the system and do not affect each other. The second are dependent variables that are 
affected only by independent variables. The three main independent variables that exist in 
biological systems are pC02, strong ion difference ([SID]), and the concentration of weak 
non-volatile acids ([AmTD (usually serum proteins and inorganic phosphates). Strong ion 
difference is defined as the net charge resulting from the combination of all strong cations 
and strong anions within that system (Stewart, 1981). 
Stewart's approach uses equations to demonstrate that kidneys do not control 
bicarbonate concentration, but instead regulate one of the independent variables, [SID], that 
determines whether strong ions are added or removed in the nephron. Since pC02 is an 
independent variable as well, both pC02 and [SID] affect the ratio of pC02 to [HC03-] (a 
dependent variable), thus affecting [Ir] (Stewart, 1981). An increase in anions results in a 
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negative [SID]. The increased concentration of anions causes an increase in the 
concentration of W, thereby lowering pH (metabolic acidosis) (Stocker et al., 1999). The 
only way to buffer this would be to increase the [SID], lowering the anion gap and ultimately 
decreasing the concentration of W (increasing pH) which would alleviate the metabolic 
acidosis (Stewart, 1981). 
Components of oral rehydration solutions 
There are many oral rehydration solutions available for treating diarrheic calves 
(Table 1). All oral rehydration solutions contain water, sodium, potassium, chloride, and an 
energy source, among other things. Most oral rehydration solutions are suitable for 
rehydration although not all have the ability to successfully correct acidosis in calves 
(Naylor, 1990). 
The main goal of an oral rehydration solution (ORS) should be to increase 
extracellular fluid volume (ECF) by replacing water and electrolytes, thereby decreasing 
dehydration and hyponatremia (Clark, 1993; Groutides and Michell, 1990). An effective 
ORS should also reduce metabolic acidosis and hyperkalaemia (Groutides and Michell, 
1990). 
A key component of ORS should be glucose, as it enhances the absorption of sodium 
and provides an energy source (Nappert et al., 2000). Most calves become hypoglycemic 
due to diarrhea and decreased glucose absorption, developing a higher dietary requirement 
for energy (Cleek et al., 1979). Both glucose and glycine are usually added to ORS to 
enhance sodium absorption, but glucose should not be added at more than 200 mmol/L of 
ORS due to changes in the osmolarity of the ORS. As more glucose is added to ORS, the 
Product Manufacturer Glucose Glycine Sodium Chloride Potassium Bicarbonate Citrate Acetate 
mmol/L mmol/L mmol/L mmol/L mmol/L mmol/L mmol/L mmol/L 
Blue Ribbon Merrick's Inc. 199.9 0.0 116.6 93.6 4.9 21.6 3.2 0.0 
Calf-Lyte Austin Lab 139.0 47.0 80.0 88.6 19.4 0.0 2.1 0.0 
Entrolyte Pfizer 158.0 36.0 105.0 51.0 26.0 80.0 0.0 0.0 
Entrolyte HE Pfizer 446.0 33.0 106.0 51.0 26.0 80.0 0.0 0.0 
Re-sorb Pfizer 129.0 45.0 80.0 78.0 17.0 0.0 1.0 0.0 
Revibe Langford 120.0 40.0 120.0 50.0 20.0 0.0 0.0 72.0 
Life Guard Norden Labs 157.5 36.0 99.8 56.4 24.1 75.5 0.0 0.0 
Biolyte Upjohn 399.0 0.0 142.0 80.0 24.0 86.0 0.0 0.0 
Hydra Vetrapharm 60.0 60.0 100.0 75.0 15.0 0.0 40.0 0.0 
H~dra-L~te VetraEharm 368.0 16.0 85.0 45.0 30.0 0.0 0.0 60.0 
Table 1. Components of a few commercially available calf oral rehydration solutions (Naylor; 1992, 1996, 1999) 
--
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ORS becomes hyperosmolar and is absorbed more slowly in the small intestine than an 
isotonic ORS (Naylor, 1996). 
Sources of energy added to ORS include glucose, lactate, citrate, and acetate (Naylor 
and Forsyth, 1986). The daily energy requirement for maintenance of a young calf is about 
2000 kcal. The daily energy requirement for maintenance with an additional weight gain of 
0.5 kg/day is 3500 kcal (Naylor, 1996). This energy requirement can be met by providing 
the calf with milk while the calf is receiving fluid therapy. 
If milk is not fed, a higher energy ORS should be fed to provide the calf with at least 
enough energy to maintain weight (Naylor, 1996). As energy content of the ORS decreases, 
weight loss is inversely proportional and increases (Fettman et al., 1986). Acetate, along 
with glucose, is a good source of energy and facilitates the absorption of water and sodium 
from the jejunum (Demigne et al., 1981). Acetate is easily metabolized in the cells of muscle 
and other tissues, requiring less oxygen than lactate, as demonstrated by the efficient 
disappearance of acetate from the blood after intravenous infusion (Park and Arieff, 1980): 
CH3Coo- + w + 02 - 2C02 + 2H20 
Bicarbonate infused intraveneously immediately alkalinizes the blood when it is 
catalyzed by carbonic anhydrase to water and carbon dioxide. Addition of sodium citrate 
may be a possible replacement for sodium bicarbonate (Hunt et al., 1992). Citrate is a 
disodium salt that is more stable during storage and may take the place of bicarbonate in 
ORS as a sodium carrier as it is a precursor to bicarbonate. 
Lactate and propionate are oxidized by liver and peripheral tissue or are converted to 
glucose (Ballard, 1972): 
2CH3CHOHCOO- + 2W + 602 - 6C02 + 6H20 
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2CH3CHOHCOff + 2W--+ C6H1206 
Sodium salts, such as sodium bicarbonate, sodium acetate, sodium lactate and sodium 
propionate, are buffers and should be added at 50 to 80 mmol/L of ORS (Naylor, 1996). The 
best alkalinizing ability is provided by sodium acetate as it is easily metabolized (Naylor and 
Forsyth, 1986). Most research has concluded that solutions with added sodium bicarbonate 
are the answer to correcting metabolic acidosis in the calf. These solutions increase pH more 
effectively than solutions without sodium bicarbonate (Booth and Naylor, 1987; Michell et 
al., 1992; Naylor and Forsyth, 1986). Oral rehydration solutions without added sodium 
bicarbonate reduce mortality and dehydration as well as solutions with sodium bicarbonate, 
but do not increase pH or reduce depression as effectively (Booth and Naylor, 1987). When 
sodium bicarbonate enters the blood, it dissociates and the bicarbonate combines directly 
with hydrogen ions and is quickly exhaled through respiration. This decreases metabolic 
acidosis, according to conventional acid-base theory (Naylor and Forsyth, 1986). 
This is not possible according to Stewart's equations. It is actually the sodium in 
sodium bicarbonate that plays the main role in decreasing metabolic acidosis. The 
bicarbonate rapidly equilibrates with pC02 and is exhaled, having no effect on acid-base 
balance. Sodium, on the other hand, enters the blood and lowers [SID], increasing the 
concentration of OH- and decreasing the concentration of W, thereby increasing the pH of 
the blood and alleviating metabolic acidosis. Bicarbonate, although added to ORS, is only a 
carrier for sodium. It does not participate in altering [Ir] since it is not an independent 
variable, but a dependent one itself (Stewart, 1981). 
Another function of sodium in ORS is to allow water to return to the extracellular 
fluid from the cells (Michell et al., 1992). Sodium concentrations in ORS should not exceed 
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145 mmol/L, as this may induce hypematremia in calves that are unable to drink more water 
than the ORS provides (Naylor, 1999). Sodium should be added to ORS at molar 
concentrations equal to the molar concentrations of glucose and glycine provided in the ORS. 
Glucose and glycine drive sodium absorption through enterocytes in a mole-to-mole ratio, 
thus if sodium concentrations exceed the combined concentration of glucose and glycine, 
then sodium is only partially absorbed in the small intestine (Constable et al., 1996; Hellier et 
al., 1973). 
Providing the calf with milk and ORS within a short time can be detrimental when the 
ORS contains bicarbonate or citrate, both of which prevent or reduce milk clotting. If the 
ORS contains acetate or lactate instead of bicarbonate or citrate, there are no detrimental 
effects on clotting and milk can continue to be fed to calves while they are receiving ORS. If 
milk is fed, sodium acetate is the best alkalinizing agent provided in ORS as it does not 
interfere with milk clotting in the abomasum (Naylor and Forsyth, 1986). 
Feeding milk while feeding ORS without bicarbonate does not affect fecal scores, 
indicating there is no extra fermentation of milk by bacteria in the gut (Garthwaite et al., 
1994). Other research indicates that feeding milk along with ORS provides enough energy to 
the calf to maintain growth and develop better fat stores, while also regenerating the 
intestinal mucosa for improved absorption (Heath et al., 1989). 
Other possible additions to ORS 
Carbohydrates 
As an alternative source of energy, dextran is added to ORS for animals that become 
hypoglycemic due to diarrhea. Dextran added to a hypertonic saline solution causes the 
expansion of plasma volume by altering the osmotic gradient and provides a sustained source 
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of glucose (Constable et al., 1996). Commercial pectins are also adequate as an alternative 
energy source to glucose, although sucrose and com syrup are not utilized because they are 
less digestible (Cleek et al., 1979). 
Amino Acids 
Glutamine is added to some oral rehydration solutions because of its effect on 
maintaining villous integrity and increasing sodium uptake. The addition of glycine at 40 
mmol/L improves nitrogen balance as well as enhancing absorption of sodium and water 
from the intestine. Improved results are obtained when glycine is added to ORS containing 
enough energy to improve the negative energy balance caused by diarrhea. Glycine added to 
low caloric density ORS is not as effective as when it is added to a high caloric density ORS 
(Fettman et al., 1986). 
Vitamins 
A viral challenge may cause the development of nutritional deficiencies and, in tum, 
accentuate the effects of the disease by suppressing immune response and resistance (Wang 
et al., 1994). This suggests that supplementing vitamins may be beneficial during a viral 
challenge. 
Vitamin A 
Although most domestic animals are fed amounts of vitamins that should be sufficient 
in their diet, there are many factors that may cause vitamin depletion and deficiency (Uni et 
al., 1998). Vitamin A deficiency is one of the most common vitamin deficiencies around the 
world and is reported to increase the incidence of diarrhea in vitamin A deficient children 
(Ahmed et al., 1990; Fawzi et al., 1995). Many researchers have reported that 
supplementation of vitamin A to vitamin A deficient children decreases the incidence of 
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diarrhea and reduces mortality (Ahmed et al., 1990; Alvarez et al., 1995; Fawzi et al., 1995). 
Calves may be at particular risk because they are born with low reserves of fat-soluble 
vitamins as they do not cross the placental membrane (Branstetter et al., 1973). Colostrum 
provides large amounts of vitamin A, however, stressors and pathogens may quickly deplete 
stores of vitamin A in the neonate. 
Morphology of the small intestine changes during vitamin A deficiency. Mucosal 
thickness and villus height are reduced and enterocyte size decreases (Uni et al., 1998). 
Overall protein synthesis and enterocyte proliferation are impaired (Uni et al., 2000; Uni et 
al., 1998). There are also decreases in goblet cell numbers in the small intestinal villi 
(Ahmed et al., 1990; Rojanapo et al., 1980; Uni et al., 2000). 
Jejunal enterocytes may undergo hypertrophy during vitamin A deficiency; there is a 
decreased ratio of RNA to DNA and protein to DNA during these periods of deficiency 
(Reifen et al., 1998; Uni et al., 1998). There is also an increase in the length of the cell cycle 
of jejunal crypt cells indicating a decrease in the proliferation of cells and a decreased rate of 
cell sloughing from the villus tip. As the DNA-synthesis cycle increases, cells are not able to 
migrate out of the crypts as quickly because of feedback regulation from differentiated cells 
not yet sloughed off the villus (Zile et al., 1977). 
Deficiency of vitamin A may also alter the biochemical and morphological 
characteristics of the small intestine by altering disaccharidase activities (Reifen et al., 1998; 
Uni et al., 2000; West et al., 1992). In vitamin A deficient animals, ribosomal capacity is 
decreased andjejunal brush border enzyme activity is low. If vitamin A is once again added 
to the diet, enzyme activity returns to normal confirming that vitamin A deficiency alters 
enzyme activity in the brush border (Reifen et al., 1998). 
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Others have shown vitamin A deficiency does not alter morphology of the intestinal 
lining (Ahmed et al., 1990; Reifen et al., 1998; Rojanapo et al., 1980; West et al., 1992; Zile 
et al., 1977). This may be a result of animals not being truly deficient in vitamin A due to 
the presence of extrahepatic reserves of vitamin A (Green and Green, 1994). 
Some research has reported a lowered resistance to specific diseases as a result of 
vitamin A deficiency (Uni et al., 2000; Uni et al., 1998). There is an impairment of mucosa! 
defense and a defect in the integrity of the epithelium when vitamin A is deficient (Warden et 
al., 1997). This may cause an increased systemic exposure to a viral challenge, decreasing 
the ability of the enterocytes to defend themselves (Ahmed et al., 1990; Wang et al., 1994). 
This is demonstrated by an increase in the weight of the spleen and an increase in the B-cell: 
T-cell ratio, indicating an increase in activity of the immune system (Ahmed et al., 1990). 
Calves challenged with Cryptosporidium parvum have decreased retinol uptake due 
to increases in the number of undifferentiated enterocytes. These immature enterocytes may 
not be able to synthesize adequate numbers of chylomicrons or they may not esterify retinol 
to the same degree as differentiated enterocytes (Holland et al., 1992). 
Function 
Vitamin A is needed to maintain normal proliferation and differentiation of cells in a 
variety of epithelial tissues (Uni et al., 1998; Zile et al., 1977). The small intestinal lining 
has a high cell turnover rate, increasing the requirement for vitamin A. Cells that may 
become adversely affected by frequent exposure to environmental stressors and pathogens, 
such as enterocytes, need a rapid turnover rate to maintain normal function (Zile et al., 1977). 
Vitamin A is an essential part of this cell replacement cycle and animals that are deficient in 
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vitamin A may be less capable in protecting their epithelial linings from such stressors 
(Filteau et al., 2001; Zile et al., 1977). 
Absorption 
Vitamin A is picked up by micelles in the lumen of the small intestine for transport, 
along with fatty acids, bile salts and other fat-soluble vitamins (Leeson and Summers, 2001). 
These micelles are secreted with nonpolar hydrophobic ends pointing in and polar 
hydrophilic ends pointing out, allowing for the solubilization of fat-soluble substances within 
the nonpolar environment (Hollander, 1981). 
Hydrolases located in the brush border and produced by the pancreas hydrolyze 
retinyl esters to retinal (Combs and Gerald, 1992; Hollander, 1981). There are different 
enzymes that hydrolyze retinyl esters to free retinal. This hydrolysis determines whether 
retinal is absorbed or excreted from the body (Schindler et al., 2002). 
Under normal conditions, the efficiency of vitamin A absorption through the 
intestinal wall is high, about 80 to 95 percent. Of this, 30 to 60 percent is esterified and 
stored in the liver. 
Transport 
Once retinal enters the enterocyte, it is attached to a carrier protein for transport 
through the aqueous cytosol to cellular organelles (Hollander, 1981). Retinal, formed by 
hydrolysis of retinyl esters or by the reduction of retinal from the cleavage of beta-carotene, 
is re-esterified with long chain fatty acids in the intestinal mucosa (Combs and Gerald, 1992). 
Rats maintain stores of up to 300 nmol of retinal in extravascular and extrahepatic 
tissues after liver retinal is depleted (Green and Green, 1994). This is confirmed by the 
presence of lecithin: retinal acyl-transferase (LRAT) in nonhepatic tissues. This enzyme 
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converts retinol to retinyl esters for storage in extrahepatic tissues, such as the intestinal wall 
(Herr et al., 1993). Cellular retinol binding protein (CRBP) is also found in the intestinal 
wall and serves as a carrier of retinol and retinal for LRAT (Herr et al., 1993). Extrahepatic 
stores of retinol may help explain why no differences are seen between vitamin A deficient 
and vitamin A sufficient groups in some trials (Warden et al., 1997). Deficient animals tend 
to conserve their extrahepatic stores, using them only when hepatic stores are depleted 
(Green and Green, 1994). 
When a stressor is introduced, such as Newcastle disease virus in chickens, plasma 
concentrations of retinol decrease dramatically not only because of impairments in 
absorption of vitamin A from the intestine, but also because of a more rapid utilization of 
vitamin A by tissues (West et al., 1992). For more vitamin A review please refer to 
Appendix B. 
Vitamin E 
Any situation that is highly stressful to an animal increases the requirement for 
vitamin E. Vitamin E deficiency in swine and cattle is characterized by dermatitis, alopecia, 
and muscular dystrophy, or white muscle disease. Vitamin E-deficient calves become 
depressed and inactive and may appear weak. Dietary intakes of polyunsaturated fatty acids 
(PUFA) and selenium affect the need for vitamin E, as do deficiencies of amino acids and 
other vitamins (Combs and Gerald, 1992). Calf milk replacers may not provide enough 
vitamin E to meet the needs of calves, especially under stressful conditions due to weaning, 
transport, disease, and confinement. Calves injected intramuscularly with supplemental 
vitamin E tend to exhibit higher growth rates and improved feed intakes (Reddy et al., 1985). 
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Vitamin E acts as an antioxidant, inhibiting oxidation and reducing free radicals, that 
are generated from covalent bonds that are cleaved (Combs and Gerald, 1992; Gonzalez et 
al., 2001; Sato et al., 1990). In diseases that are characterized by a high production of free 
radicals, such as inflammatory bowel disease, supplementation of vitamin E decreases the 
amount of oxidative damage (Gonzalez et al., 2001). Supplementing dietary alpha-
tocopherol helps maintain membrane integrity (Burton et al., 1983; Combs and Gerald, 1992; 
Gonzalez et al., 2001 ). 
Absorption 
Vitamin E absorption is dependant on the absorption of other lipids because it is a fat-
soluble vitamin (Combs and Gerald, 1992; Hollander, 1981). The first site of absorption is 
the proximal small intestine where alpha-tocopherol is hydrolyzed by bile salts and 
pancreatic juices and absorbed as a free alcohol via passive diffusion (Combs and Gerald, 
1992; Hollander, 1981). Once through the membrane, it is transported to the liver by 
chylomicrons, very low-density lipoproteins (VLDL) and high-density lipoproteins (HDL) 
(Bjorneboe et al., 1986; Bjorneboe et al., 1987; Cohn et al., 1988; Kastner et al., 1995; 
Massey, 1984). Alpha-tocopherol is then absorbed into the intestinal lymph and transported 
unchanged to the liver (Bjorneboe et al., 1986; Burton et al., 1983). 
Storage 
There are two storage pools of vitamin E in tissues. A fixed pool that turns over 
slowly is located in adipose tissue, and a labile pool that turns over rapidly is usually located 
in cellular membranes of other tissues, such as small intestine or liver. During alpha-
tocopherol deficiency, stored alpha-tocopherol is rapidly depleted from the labile pool, 
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making plasma and liver most susceptible to deficiency (Combs and Gerald, 1992). For 
more review of vitamin E please refer to Appendix B. 
Vitamin A and E interactions 
Several researchers have reported interactions between vitamin A and vitamin E in 
vivo. High dietary vitamin A decreases plasma alpha-tocopherol (Bieri and Tolliver, 1982; 
Franklin et al., 1998) as well as liver alpha-tocopherol levels (Combs, 1976; Dicks et al., 
1959; Eicher et al., 1997; Sklan and Donoghue, 1982). Conversely, deficiencies in retinol 
increase hepatic alpha-tocopherol levels (Roels et al., 1964). 
The form of retinol provided in the diet also affects plasma and hepatic 
concentrations of vitamin E. Increases in dietary retinoic acid decrease absorption of free 
and esterified alpha-tocopherol independently of triglyceride absorption. It is theorized that 
feeding this form of vitamin A may alter the physical or chemical conditions present in the 
intestinal wall, preventing or decreasing the absorption of alpha-tocopherol (Bieri and 
Tolliver, 1982) 
Plasma vitamin A concentrations are also affected by the level of intake of vitamin E. 
Plasma vitamin A concentrations are decreased during high or moderate dietary vitamin E 
intakes (Abawi et al., 1985; Eicher et al., 1997; Napoli et al., 1984). However, although 
plasma vitamin A concentrations are decreased, hepatic vitamin A stores are increased 
(Combs and Gerald, 1992; Napoli et al., 1984; Roels et al., 1964). 
In the small intestine, high concentrations of fat-soluble vitamins compete for 
hydrolysis by the brush border enzymes (Abawi et al., 1985; Franklin et al., 1998). Once in 
the enterocytes, high vitamin concentrations compete for transfer by fat-soluble carriers 
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(Eicher et al., 1997). For more review of vitamin A and E interactions, please refer to 
Appendix B. 
Vitamin C 
Vitamin C is a water-soluble antioxidant vitamin found in many food sources, 
although almost all animals are capable of synthesizing it by way of the glucuronic acid 
pathway. Animals that completely rely on dietary sources include humans, primates, guinea 
pigs, and fruit bats (Combs and Gerald, 1992). Although cattle are generally able to 
synthesize their own ascorbic acid, active synthesis does not begin until about 3 weeks of age 
(Combs and Gerald, 1992; Cummins and Brunner, 1991). 
Young calves therefore require an exogenous source of ascorbic acid, usually 
provided by colostrum and milk, to be able to reduce radicals in the aqueous portion of the 
cell (Black and Hidiroglou, 1996; Bouda et al., 1980). Although deficiency of vitamin C is 
rare, animals may become deficient during stressful situations or in high production 
environments (McDowell, 1989). 
A decrease in plasma ascorbate levels occurs in calves during infections in either the 
enteric or respiratory systems (Bouda et al., 1980; Cummins and Brunner, 1991). Stressful 
conditions alter the rate of endogenous synthesis. In addition, calves that are housed in 
colder environments are older when endogenous ascorbate synthesis is initiated than calves 
that are housed in more protected environments (Cummins and Brunner, 1991). 
Absorption 
Species that can synthesize their own ascorbic acid absorb it via passive diffusion 
through the wall of the small intestine into enterocytes. Species that cannot synthesize 
ascorbic acid utilize two different methods of absorption through small intestinal membranes. 
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When dietary intake is low, sodium-dependant active transport is the primary absorptive 
mechanism. When dietary intake is adequate or high, passive diffusion becomes the primary 
absorptive mechanism (Combs and Gerald, 1992; McDowell, 1989). 
Functions 
The primary functions of ascorbic acid are based on its reduction and oxidation 
capabilities (Black and Hidiroglou, 1996; McDowell, 1989; Sato et al., 1990). It is able to 
scavenge free radicals in aqueous portions of a cell (Niki, 1991; Sato et al., 1990). Once it 
scavenges a free radical, it becomes oxidized to dehydroascorbate, which is then reduced 
back to ascorbate by GSH-dehydroascorbate reductase (Niki, 1991). For more review of 
vitamin C please refer to Appendix B. 
Vitamin C and E interactions 
When vitamin E recycles itself from alpha-tocopheroxyl back to alpha-tocopherol, it 
requires a reducing agent such as ascorbic acid (Combs and Gerald, 1992; Doha et al., 1985; 
Ginter et al., 1982; Niki, 1991; Sato et al., 1990). Some research indicates that in vivo 
recycling of vitamin E by vitamin C may not happen due to compartmentalization of vitamin 
C in the aqueous cytosol and tocopheroxyl in the lipid membrane (Combs and Gerald, 1992; 
Sato et al., 1990). Others reported that, although compartmentalization exists, alpha-
tocopheroxyl radicals are available to vitamin C because the polar alpha-tocopherol head is 
closer to the membrane surface (Doha et al., 1985; Niki, 1991; Sato et al., 1990). In support 
of this theory, Niki (1991) reported that the efficiency with which ascorbic acid reduces 
tocopherol decreases as the tocopheroxyl radical is located deeper in the membrane. 
The spatial problems associated with compartmentalization may also be overcome by 
the glutathione peroxidase system which actively shuttles electrons from soluble phases of 
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the cell to radicals in cell membranes (Chen and Chang, 1978; Combs and Gerald, 1992). 
Vitamin C interacts with the glutathione peroxidase system, which interacts synergistically 
with alpha-tocopherol, thereby sparing alpha-tocopherol (Chen and Chang, 1978). 
Vitamin C deficient guinea pigs tend to have low concentrations of alpha-tocopherol 
in liver, lungs and kidneys resulting from an increased susceptibility of vitamin E to 
oxidation without the presence of the reducing ability of vitamin C (Hruba et al., 1982). For 
more review of vitamin E and C interactions please refer to Appendix B. 
Vitamin A and C interactions 
Although interactions between vitamins A and C do exist, there are no interactions 
during absorption or transport in enterocytes. For other interactions of vitamins A and C 
please refer to Appendix B. 
Serum protein fraction 
Serum protein fraction consists of elevated levels of growth factors, such as insulin-
like growth factors and transforming growth factor-~. These growth factors stimulate 
enterocyte differentiation and intestinal growth, especially after viral damage. Growth 
factors play a role in re-establishing the mucosa! barrier that is affected by viral infection or 
damage, increasing primary defense in the gut. 
Insulin-like growth factor-I 
Insulin-like growth factors (IGF) are part of the insulin family of hormones and 
growth factors, including IGF-I, IGF-II and relaxin. Insulin-like growth factors are heat and 
acid stable allowing them to be ingested and to reach the small intestine intact (Baumrucker 
and Blum, 1993). 
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In the small intestine, IGF-1 binds to receptors located throughout in crypt and villus 
areas, as well as in the muscularis and submucosal layers of the small intestine (Morgan et 
al., 1996; Young et al., 1990). The IGF-1 receptors are located on basolateral and apical 
membranes of the jejunum (Morgan et al., 1996). Although IGF receptors are located all 
along the length of the small intestinal, the highest concentration of IGF-1 binding is in the 
jejunum due to highest receptor concentration, a higher concentration of binding proteins or 
an altered response in the jejunum to IGF-1 (Young et al., 1990). 
Type I IGF receptors have greater affinity for IGF-1 than IGF-11 and the least affinity 
for insulin (Baumrucker et al., 1994; Schober et al., 1990). The affinity of IGF-1 for type I 
receptors is about five times more potent than IGF-11 and one thousand times more potent 
than insulin (Baumrucker et al., 1994). Type II IGF receptors have greater affinity for IGF-11 
than IGF-1, but do not bind insulin (Baumrucker et al., 1994; Schober et al., 1990). 
The presence of IGF-1 receptors in differentiated villus cells and proliferating crypt 
cells may indicate a role for IGF-1 in cellular maturation (Morgan et al., 1996). Levels of 
IGF-1 receptors are maintained while concentrations of IGF-11 receptors decrease during 
suckling (Young et al., 1990). When IGF-1 is added to the diet, type I receptors are 
upregulated due to the increased concentration of IGF-1 (Baumrucker et al., 1994; Schober et 
al., 1990). The highest concentration of IGF-1 binding to receptors occurs at a pH of 7.8 to 
8.2, indicating that the small intestine is a prime site of IGF-1 binding (Schober et al., 1990). 
Decreases in binding are usually due to a decrease in receptor numbers and not a decrease in 
affinity (Schober et al., 1990). This may be a way for cells to regulate the effects of IGF-1 on 
intestinal epithelium (Schober et al., 1990). 
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Insulin-like growth factor binding proteins (IGFBP) are present in plasma and milk 
and function to bind IGF (Clemmons, 1991). Four specific IGFBPs (IGFBP 1, 2, 3, and 4) 
have been identified in plasma (Clemmons, 1991). The binding protein IGFBP-3 has the 
greatest affinity to binding IGF-1 and is present in the highest concentrations in plasma 
(Clemmons, 1991). Infusion of IGF-1 stimulates an increase in the serum concentration of 
IGFBP-3, indicating that serum concentrations of IGFBP-3 are responsive to serum 
concentrations of IGF-1, thus tightly regulating IGF-1 availability to peripheral tissues 
(Clemmons et al., 1989). Any excess IGF-1 that is not bound to IGFBP-3 binds to IGFBP-1, 
IGFBP-2, or IGFBP-4 (Clemmons, 1991). 
Binding of IGFs by IGFBPs affects the utilization of IGFs in the neonate. Cells 
secrete different concentrations of each IGFBP, regulating the amount of specific IGFs that 
are needed locally (Clemmons, 1991; Philipps et al., 1995). These binding proteins partition 
IGFs between receptors and the vascular compartment (Clemmons, 1991). Binding of an 
IGFBP to IGF-1 or IGF-11 in plasma forms a complex that, although capable of crossing the 
endothelium, does not pass through capillary membranes. This provides a reservoir of these 
growth factors for use by peripheral tissues (Clemmons, 1991). It is also possible that once 
the complex passes through the capillary endothelium, the IGFBPs direct IGFs to specific 
tissues (Clemmons, 1991). 
The IGFBP have a greater affinity for binding IGFs than IGF receptors (Clemmons, 
1991). Although IGFBPs bind IGFs, IGFBPs themselves are also able to bind to type I 
receptors (Clemmons, 1991). Once the complex is bound to a receptor, it is not known 
whether IGFs are then transferred off the IGFBP or whether they are transferred as a 
complex through the membrane (Clemmons, 1991). 
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Neonatal rats fed IGF-1 result in hyperplasia of the small intestine, indicated by an 
increase in crypt length, villus height and number of cells emerging from the crypts, resulting 
in a new steady-state equilibrium in the small intestinal epithelium (Steeb et al., 1994). This 
increase in villus cell density increases intestinal surface area which then increases absorptive 
capacity of the small intestine in neonatal rats (Burrin et al., 1995; Steeb et al., 1994). This 
improvement in absorptive capacity leads to an improved feed efficiency in rats 
subcutaneously infused with rhlGF-1 compared to control rats (Steeb et al., 1994). The 
increase in this cell population is also reflected in an increase in tissue weight and protein and 
RNA content of the duodenum in IGF-treated rats (Burrin et al., 1995; Steeb et al., 1994). 
Absorption of IGF-1 is low in the small intestine of the neonatal rat (Burrin et al., 
1995). This may also be true in other species. Plasma concentrations of IGF-I in calves fed 
six feedings of colostrum containing high concentrations of IGF-I were not different than 
calves fed diluted colostrum (Rauprich et al., 2000). 
Concentrations of plasma IGF-I were not altered in pigs infected with rotavirus, 
however, they were affected by malnourishment. Lowered plasma concentrations of IGF-1 in 
malnourished, rotavirus-infected pigs may contribute to slower recovery of the small 
intestine. Concentrations of intestinal IGF-I binding proteins (IGFBP) are increased 
following rotavirus challenge in pigs, indicating that IGFBP may help regulate IGF effects on 
the small intestine (Zijlstra et al., 1997). The mRNA concentration of IGF-I was decreased 
in protein-depleted rats. When rats were allowed a protein-rich diet, jejunal concentrations 
of IGF-I increased and IGF-I receptors decreased (Qu et al., 1998). 
Rats treated with dexamethasone, which disrupts intestinal morphology, benefit from 
IGF-I infusion with an increase in gut mass by 60% when compared with rats treated with 
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dexamethasone but not infused with IGF-1. This indicates the gut is one of the most 
responsive target tissues for IGF-1 due to either increased receptor number, increased 
receptor sensitivity, or increased delivery of IGF-1 from the circulation to the gut. The 
increase in gut mass increases surf ace area due to increased villus height and mucosal area, 
leading to an increase in nutrient uptake even if gut morphology is negatively affected (Read 
et al., 1992). 
Transforming growth factor-P J and ·P2 
Transforming growth factor-Ps (TGF-P) have a molecular mass of 25,000 kDa and 
consist of polypeptide dimers linked by sulfur bonds (Ruscetti et al., 1998). There are three 
different genes that encode for TGF-Ps in the mammalian genome, producing TGF-P 1, TGF-
p2, and TGF-P3 (Roche et al., 2000; Ruscetti et al., 1998). Most mature cells are able to 
produce one of the isoforms of TGF-Ps during tissue repair and inflammation (Roche et al., 
2000). Cells have three receptor types (I, II, and ill) that are capable of binding all three 
TGF-Ps in mammals (Letterio and Roberts, 1998). 
Cell adhesiveness is regulated by TGF-Pl through increased expression of 
extracellular matrix proteins as well as increased cell surf ace receptors. The increase in 
matrix protein expression may strengthen tight junctions between cells, maintaining the 
mucosal barrier in the intestine (Roche et al., 2000). In response to addition of TGF-P into 
cell culture there is an increase in the incorporation of matrix proteins, such as fibronectin 
and collagen-related proteins, into cells, changing the extracellular matrix composition. This 
increase in extracellular proteins occurs in the extracellular matrix, the intracellular matrix 
and the medium of all cellular compartments, with the largest increase in the extracellular 
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matrix. The ability of cells to incorporate these proteins is also stimulated by TGF-P (lgnotz 
and Massague, 1986). 
Transforming growth factor-P is a potent inhibitor of cellular proliferation. The 
addition of TGF-P does not increase [3H]-thymidine incorporation into small intestinal cells 
in vitro (Ciacci et al., 1993; Dignass and Podolsky, 1993; Kurokowa et al., 1987). However, 
there are no decreases in cell number when compared to control cells indicating that TGF-P 
is not cytotoxic (Dignass and Podolsky, 1993; Kurokowa et al., 1987). The presence of 
growth factors that stimulate cell proliferation, such as IGF-1, insulin or EGF, do not override 
the inhibition of cell proliferation by TGF-p, indicating that TGF-P affects cell proliferation 
through the same pathway as other growth factors. The addition of TGF-P either blocks an 
earlier step in the pathway (Kurokowa et al., 1987) or it may have a higher affinity to the 
same receptors as other growth factors (Dignass and Podolsky, 1993). Interestingly, the 
addition of TGF-P to cell culture also stimulates sucrase activity, indicating TGF-P has a role 
in promoting the differentiation of epithelial cells (Kurokowa et al., 1987). 
Detrimental effects of viral challenge with Cryptosporidium parvum on colonic cells 
are ameliorated when the cells are treated prior to viral challenge with TGF-Pl. This is not 
the case with cells that are TGF-P 1 treated during or after challenge. Cells pretreated with 
TGF-P 1 maintain their mucosa! barrier and cell necrosis that results from C. parvum 
infection is reduced accordingly (Roche et al., 2000). 
Any type of epithelial injury causes an upregulation of TGF-P 1, stimulating 
restitution, which is when epithelial cells surrounding the injury migrate across and take the 
place of injured and sloughed epithelial cells (Ciacci et al., 1993; Dignass and Podolsky, 
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1993). Although TGF-Pl is secreted as a latent complex, cells produce plasmin-like protease 
activity that activates TGF-Pl (Dignass and Podolsky, 1993). 
Colostrum also contains many growth factors and growth hormones, such as insulin-
like growth factors and transforming growth factors. Small intestinal villus development is 
changed by the prolonged feeding of colostrum for 6 feedings to neonatal calves compared to 
calves fed colostrum only once or calves fed only milk replacer (Buhler et al., 1998). 
Hyperplasia of the intestinal epithelium occurs, resulting in a decrease in crypt depth: villus 
height ratios in calves (Buhler et al., 1998) and rats (Berseth et al., 1983) fed colostrum, 
indicating an increase in differentiated cells moving up the villus and shedding off. 
Xylose absorption is higher in calves fed colostrum for 6 feedings than in calves fed 
colostrum only once or calves fed only milk replacer, suggesting an increase in absorptive 
capacity due to increased numbers of differentiated enterocytes and greater intestinal surface 
area (Buhler et al., 1998). 
Immunoglobulin G 
A method to prevent colonization of bacteria in the small intestine is to block the 
binding sites and receptors that are available to bacterial lectins by binding the sites with 
receptor analogues, such as glycoproteins or immunoglobulins (Nollet et al., 1999). 
Immunoglobulin G (IgG) can be fed even after the neonatal intestine cannot absorb the 
immunoglobulins for passive immunity, approximately after the calf is 24 hours of age. The 
IgG is also partially resistant to digestion in the stomach and has the ability to reach and 
affect the small intestine (Brock et al., 1977). Calves treated orally with immunoglobulins 
have a less severe response to E. coli than calves not treated with immunoglobulins (Quigley 
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and Drew, 2000). Treatment with immunoglobulins may also benefit calves if infection with 
other enteric pathogens occurs (Quigley and Drew, 2000). 
Calves challenged with cryptosporidium have improved diarrhea and reduced gut 
permeability when orally fed with bovine serum concentrate, containing concentrated 
amounts of IgG, IGF-1, and TGF-PI (Hunt et al., 2002). The potential mechanism may be 
due to the prevention of attachment of cryptosporidial organisms, reducing replication and 
invasion of the gut (Hunt et al., 2002). 
Serum protein separation 
Blood is collected from cows that passed veterinary inspection before slaughter. 
Blood is freshly obtained from abattoirs under USDA inspection. Anticoagulant is added to 
blood and centrifuged to separate plasma and red blood cells. Plasma is defibrinated and 
resulting plasma is concentrated by ultrafiltration. This plasma is then spray-dried to produce 
powder containing elevated levels of growth factors and IgG. 
Summary 
The epithelium of the gastrointestinal tract is the first line of defense to disease and 
infection. The ability to diminish effects of gastrointestinal injury and preserve normal 
homeostasis is important for health and performance of neonates. Current oral rehydration 
solutions restore acid-base balance, but with the addition of specific vitamins or growth 
factors, they may also have the ability to help restore the integrity of the epithelial barrier. 
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CHAPTER2 
EFFECTS OF AN ORAL REHYDRATION SOLUTION WITH ADDED FAT-
SOLUBLE VITAMINS OR BOVINE SERUM PROTEINS ON SMALL INTESTINAL 
ABSORPTIVE CAPACITY 
A paper, a portion of which is to be submitted to the Journal of Dairy Science 
S. I. Wawrzyniak, H.D. Tyler, J.D. Quigley, III, M.L. O'Brien, K.J. Touchette, J. A. Coalson 
ABSTRACT 
Young calves commonly become infected with viruses and bacteria that damage the 
intestinal lining. Deficiencies in fat-soluble vitamins also occur in young calves and may 
impair the rate of differentiation of intestinal epithelial tissues, especially following enteric 
infections. To enhance recovery of small intestinal function following a coronavirus 
challenge, either fat-soluble vitamins or bovine serum proteins, containing IgG, TGF-~ and 
other growth factors, were added to an oral rehydration solution (ORS) for 32 Holstein and 
Jersey calves. Calves were housed individually and offered water ad libitum and milk 
replacer at 10% of BW daily. Treatment one consisted of a commercial ORS (COM) and 
treatment two consisted of a control ORS (CON). Treatment three consisted of CON with 
added antioxidants, to provide 70,000 IU of vitamin A and 300 IU of vitamin E per day 
(VIT). Treatment four consisted of CON with added bovine serum proteins (GFR). After a 
2 d adjustment, calves were orally challenged with 5x106 plaque-forming units of a 
moderately virulent bovine coronavirus isolate. Xylose (0.5 g/kg of BW) was administered 
orally once daily for 6 d and jugular blood was sampled at 0, 0.5, 1, 1.5, 2, 2.5, 3, 3.5, 4 h 
post-dosing. Hematocrits, fecal dry matter, rectal temperatures, attitude scores and 
dehydration scores were recorded once daily. Concentrations of serum xylose increased with 
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time post-dosing, but did not vary by treatment. Hematocrits and other clinical scores were 
not significantly different (P >0.05) between treatments. In this model, antioxidants or 
bovine serum proteins did not appear to enhance intestinal recovery from a coronavirus 
challenge when added to ORS. 
INTRODUCTION 
Neonatal calf diarrhea is a major cause of death and economic loss in the dairy 
industry (Constable et al., 1996; Torres-Medina et al., 1985). Coronavirus is one of the more 
common pathogens causing calf scours (McDonough et al., 1994). Pathogens that affect 
mucosal function of the intestinal tissues, such as coronavirus, destroy villus architecture and 
decrease absorptive surface area of the small intestine (Bridger et al., 1978; Clark, 1993; 
Holland et al., 1992; Saif et al., 1986). Loss of epithelial function results in malabsorption of 
water, sodium, and chloride (Torres-Medina et al., 1985). Continued diarrhea increases the 
risk of dehydration and hypoglycemia and, if not treated, eventually leads to death (Clark, 
1993; Pensaert and Callebaut, 1994). 
When calves develop diarrhea, treatment with oral or intravenous fluid therapy may 
aid in avoiding problems such as metabolic acidosis (Booth and Naylor, 1987; Groutides and 
Michell, 1990). In addition, oral rehydration solutions (ORS) are formulated to maintain 
hydration, replace lost electrolytes, and provide an energy source for the diarrheic calf 
(Nappert et al., 2000). 
Some additions to ORS can include specific fat soluble and antioxidant vitamins. 
Calves may be at particular risk of deficiency in fat-soluble vitamins and are born with low 
reserves because fat-soluble vitamins do not cross the placental membrane (Branstetter et al., 
1973). Deficiencies in fat-soluble vitamins, such as vitamin A, induce impairments of 
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mucosal defense and defects in the integrity of the small intestinal epithelium (Warden et al., 
1997). This may cause an increased systemic exposure to a viral challenge, decreasing the 
ability of enterocytes to defend themselves (Ahmed et al., 1990; Wang et al., 1994). 
Morphology of the small intestine changes during vitamin A deficiency (Uni et al., 
1998). Changes such as increased permeability of the small intestine and decreased solute 
absorption may lead to diarrhea (Filteau et al., 2001). Supplementation of vitamin A to 
vitamin A deficient children decreases incidence of diarrhea and reduces mortality (Ahmed et 
al., 1990; Alvarez et al., 1995; Fawzi et al., 1995). Vitamin A supplementation maintains 
tight junctions in the small intestine of infants born to HIV-infected women, decreasing 
intestinal permeability and maintaining membrane integrity (Burton et al., 1983; Combs and 
Gerald, 1992; Filteau et al., 2001; Gonzalez et al., 2001). 
In conditions that are characterized by a high production of free radicals, such as 
inflammatory bowel disease, supplementation with vitamin E (Gonzalez et al., 2001; 
Srigiridhar and Nair, 2000) decreases oxidative damage to the colon. This may also occur in 
the small intestine. 
Small intestinal epithelium that has been damaged due to pathogens is one of the most 
sensitive organs to additions of growth factors (Read et al., 1992). Calves challenged with 
Cryptosporidium parvum have reduced gut permeability when dosed orally with bovine 
serum concentrate containing elevated amounts of immunoglobulin G (IgG), insulin-like 
growth factor-I (IGF-I), transforming growth factor-~1 (TGF-~1) and transforming growth 
factor-~2 (TGF-~2) (Hunt et al., 2002). Rats treated with dexamethasone, which disrupts 
intestinal morphology, benefit from IGF-I infusion with a 60% increase in gut mass as well 
as increased intestinal surface area when compared to control rats (Read et al., 1992). 
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Colonic cells treated with TGF-Pl before challenge with Cryptosporidium parvum maintain 
their mucosa! barrier as well as membrane integrity (Roche et al., 2000). 
Therefore, the objective of this study was to enhance the rate of recovery of small 
intestinal absorptive function following a coronavirus challenge by supplementing an oral 
rehydration solution with either vitamins A and E or a bovine serum fraction containing 
elevated levels of growth factors. 
MATERIALS AND METHODS 
The trial utilized 32 Jersey and Holstein male calves (3-5 d of age) purchased from 
sale barns during the month of March 2001. Following arrival, calves were randomized into 
8 blocks of 4 calves and weighed before being placed in individual plastic hutches bedded 
with wood shavings. Four pints of commercial oral rehydration solution (ORS) were fed on 
arrival. Calves were offered water ad libitum and fed a complete (20% fat and 20% protein) 
commercial milk replacer at a rate of 5% of bodyweight, twice daily. Feed refusals were 
monitored and recorded. No hay or starter was offered. 
Treatments 
Treatments began approximately 12 h after viral challenge, and were provided at 10% 
of initial bodyweight, twice daily, for 3 d. Treatment one (COM) calves were fed a 
commercial oral rehydration solution (Table 1). Treatment two (CON) calves were fed an 
oral rehydration solution formulated to include 4g/lb of ascorbic acid (Table 2). Treatment 
three (VIT) calves were fed CON with the addition of 70,000 IU of retinyl acetate and 300 
IU of d-a.-tocopherol acetate per day. Treatment four (GFR) calves were fed CON with the 
addition of a serum protein fraction consisting of elevated levels of IgG, IGF-1, TGF-Pl and 
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TGF-P2 (Table 3). Batches were mixed daily by treatment order to minimize risk of 
contamination. 
Table 2. Ingredient composition of commercial oral rehydration solution 1. 
Ingredient 
Sodium 
Chloride 
Potassium 
Dextrose 
Glycine 
Sodium Bicarbonate 
Citric Acid 
mmol/L 
145.87 
117.01 
5.11 
249.83 
1.89 
27.03 
3.69 
1 Merrick's, Inc. Blue Ribbon Electrolyte Formula, Union Center, WI 
Table 3. Ingredient composition of control oral rehydration solution2• 
Ingredient 
Sodium 
Chloride 
Potassium 
Dextrose 
Maltodextrin 
Glycine 
Sodium Citrate 
Calcium Lactate 
Ascorbic Acid 
2 Merrick's, Inc., Union Center, WI 
mmol/L 
135.71 
88.01 
188.73 
111.25 
111.25 
40.06 
25.33 
1.92 
2.90 
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Table 4. Ingredient composition of plasma serum fraction with elevated 
levels of growth factors3. 
Ingredient 
Total protein 
Albumin 
IgG 
Moisture 
Ash 
Standard Platelet Count 
Endotoxin 
TGF-Pl 
TGF-P2 
IGF-1 
Salmonella 
2 APC, Inc. Ames, IA. 
Concentration 
93.24% 
56.64% 
19.70% 
3.36% 
0.61% 
600CFU/g 
0.311 EU/g 
765 ng/g 
9 ng/g 
1368 ng/g 
negative 
Scoring, blood sampling and analysis 
Fecal samples were obtained and analyzed daily for dry matter content. Starting on 
the second day, xylose was fed orally at 0.5 g/kg of BW. Jugular blood samples were 
obtained prior to xylose feeding to provide baseline values at time 0 and then after xylose 
feeding at 0.5, 1, 1.5, 2, 2.5, 3, 3.5, and 4 h. An additional 3 cc sample of venous blood was 
obtained into a heparinized tube at time 0 during collection days and immediately analyzed 
for hematocrit. Serum was separated from the sample by centrifugation at 3600 x g for 15 
minutes, collected, and frozen at -20 F for later analysis of xylose and haptoglobin 
concentrations. Xylose concentrations were determined spectrophotometrically by the 
method described by Eberts et al. (1979). Haptoglobin was determined 
spectrophotometrically using a commercial kit (TriDelta LTD., Morris Plains). Xylose was 
dosed and serial blood samples collected on d 1, 2, 3, 4, 5, and 6. Calves were challenged 
orally with bovine coronavirus (5 x 106 plaque forming units of a moderately virulent 
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coronavirus isolate) following the 4 h blood collection period on d 2. Treatments were 
provided on d 3, 4, and 5. 
All performance scores were evaluated and recorded daily by a single person; these 
scores included fecal scores on a four-point scale (l=firm, 2=soft, 3=runny, 4=watery), 
attitude scores on a four-point scale (l=alert, 2=slightly depressed, 3=depressed, 4=laterally 
recumbent), dehydration scores using skin tent time based on a three-point scale (l=<ls, 
2=2-3s, 3=>3s), and a score based on rectal temperature (1=100-102.5, 2=<99.9, 3=>102.6). 
Statistical analysis 
Analysis of variance was performed using the mixed procedures of SAS 8.1 (SAS, 
1999) and a model for a completely randomized design. The xylose data were log 
transformed and sorted by treatment. Mean values of data from days 1 and 2 prior to viral 
challenge were used as a covariate in the model. Least squares means were used to evaluate 
treatment differences for xylose concentrations, performance parameters and haptoglobin 
values. Significance was declared at P < 0.05 and trends at P < 0.15. Treatment means were 
compared using the method of least significant differences. 
RESULTS 
Xylose concentrations 
Treatment values for xylose concentrations in all figures represent covariate-adjusted 
least squares means. Changes in xylose concentrations (mg/dl) for calves grouped by 
treatments over time are shown in Figure 1. Changes in xylose concentrations (mg/dl) for 
calves grouped by day are shown in Figure 2. There were no significant differences (P > 
0.05) in xylose concentrations between treatment groups for any day post-viral challenge. 
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There were time effects evident for xylose concentrations within each day (P < 0.05). 
Figure 3 shows changes in xylose concentrations {mg/dl) over sampling times ford 3, the 
first day of ORS treatment for the various treatment groups. Although xylose concentrations 
increased over time for all treatment groups, xylose concentrations for GFR tended to be 
higher at 120 and 210 minutes when compared to CON (P < 0.15). Figure 4 shows changes 
in xylose concentrations (mg/dl) over sampling times ford 4, the second day of ORS 
treatment for the various treatment groups. Xylose concentrations again increased in all 
treatment groups over time. Xylose concentrations tended to be higher for GFR than VIT at 
90 and 150 minutes (P < 0.15), and for GFR than CON at 120 and 210 minutes (P < 0.15). 
Figure 5 shows changes in xylose concentrations (mg/dl) over sampling time ford 5, the last 
day of ORS treatment for the various treatment groups. Xylose concentrations increased in 
all treatment groups over time. Xylose concentrations tended to be higher for GFR than 
CON at 180 and 210 minutes (P < 0.16). Figure 6 shows changes in xylose concentrations 
{mg/dl) over sampling time for d 6. 
Although there were no significant differences between any treatment groups, peak 
xylose concentrations tended to increase over time for CON and VIT treatment groups (P < 
0.15). First day post-challenge peak concentrations of xylose tended to be higher for CON 
calves than peak xylose concentrations of 3 consecutive days pre-challenge. Peak xylose 
concentrations for treatment CON for the second and third day post-challenge tended to be 
higher than peak xylose concentrations for the first day post-challenge. For VIT treatment 
calves, peak xylose concentrations for two and three days pre-challenge and one day post-
challenge tended to be higher than peak concentrations of xylose for three days pre-challenge 
(first day of the trial). 
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Performance parameters 
Least squares means of fecal scores are shown in Figure 7. There were no significant 
differences between treatment groups, although all treatment groups increased numerically 
on day 2, before viral challenge. Least squares means of fecal dry matter scores are shown in 
Figure 8. There were no significant differences between treatment groups, although dry 
matter was numerically lower for all treatment groups on day 2, correlating to the observed 
increase in scour scores. Least squares means of dehydration scores are shown in Figure 9. 
There were no significant differences in dehydration scores between treatments, although 
dehydration scores for all treatment groups were numerically higher on day 2, correlating to 
both the increase in fecal scores and decrease in fecal dry matter. Least squares means of 
attitude scores are shown in Figure 10. There were no significant differences in attitude 
scores between treatment groups. Attitude scores numerically increased on day 2, indicating 
a decline in attitude, corresponding to an increase in fecal scores and dehydration that day. 
Least squares means for temperature are shown in Figure 11. There were no significant 
differences in temperature between treatment groups. Least squares means for hematocrit are 
shown in Figure 12. There were no significant differences in hematocrit between treatment 
groups. In addition, there were also no significant differences in feed refusals between 
treatments (data not shown). 
Haptoglobin concentrations 
Least squares means of haptoglobin concentration (mg/ml) are shown in Figure 13 for 
day 2, one day pre-challenge, day 4, one day post-challenge and day 6, three days post-
challenge. There were no significant differences in haptoglobin concentrations between 
treatments for any time periods measured. 
5.000 
4.500 
4.000 
_ 3.500 I 
- Ill - ii lmlll -.- J I Iii - -.- l•A ., 3.000 
c I m II - - i. II ~.L- -Tm l ~B Cl) 2.500 8 2.000 I - Ill - Ill - Ill - Ill .J.mlllll loC 
"' 1.500 I IHHHHI-~ 1.000 .. T.._ 
0.500 
0.000 
1 2 3 4 5 6 
Days 
Figure 7. Least squares means of fecal scores for calves receiving different ORS formulations throughout sampling days. A, 
Commercial; B, Control; C, Added antioxidants; D, Added serum fraction. 
VI 
0\ 
0.8 
0.7 
0.6 
Ci I llllm I~ ..__. 0.5 .. llr,..T I I,.. II 1.a l•A 
~ 0.4 I •Ill - ,..II "T""-r- T ~ -~ 11-rl I~ I~ B - 1• I llli -· -~ M~ ~ loc ca ~ 0.3 1 • -I •1 - Ii - ---- - - I D 
0
·
2 Tll 111 rllTll ;-m Ill . 
0.1 
0 
1 2 3 4 5 6 
Days 
Figure 8. Least squares means of fecal dry matter throughout sampling days for calves receiving different ORS formulations. A, 
Commercial; B, Control; C, Added antioxidants; D, Added serum fraction. 
Ut 
-......) 
3.000 
2.500 
<?' 2.000 I 1TT •• T _ I 11A ,... ......., 
~ 1.500 I 11r1 T TT • 11 -r-r-=E 11~ 111 s 
0 
~ 1.000 t.-.11 ttit-m oC 
0.500 I ~ .... """ --... """ ~-.. """ --... """ ~ """ _,.. - I Iii D I 
0.000 
1 2 3 4 5 6 
Days 
Figure 9. Least squares means of dehydration scores throughout sampling days for .calves receiving different ORS formulations. 
A, Commercial; B, Control; C, Added antioxidants; D, Added serum fraction. 
Vl 
00 
3.000 
2.500 
----. 2.000 I 
~ - - I Tlill T l•A I 
~ I 
Cl.> 1.500 - - au 111 .,... T .L TT l~B L. I 0 T • 11 .l.TrlT -- ~~ Ill~ loC u 
"' 1.000 ~ I-II t-111-111-11 ~ ~ 
I ~~ ~~ ~~ ~~ ~~ ~~ 
0.500 
0.000 
1 2 3 4 5 6 
Days 
Figure 10. Least squares means of attitude scores throughout sampling days for calves receiving different ORS formulations. A, 
Commercial; B, Control; C, Added antioxidants; D, Added serum fraction. 
U\ 
\0 
104.0 
103.0 
102.0 
I l~I~ ~"'\'1111 -1111 ~II I I I I I I 
..-.. I ~~'-.'"\111::::::==::1 ~,,,,..,,.. ~ -.._,, ....... ,'11 l===S::::==I -.,.,,,,,, s==s===I ~~'-.... I ,•A 
~ 101.0 Tm1I ~ Iii --~~r l ~B 
~ 100.0 ~ ~ -----~ II ~IL loC 
I- I -;:lo._'-'-''-" -====>O -~'-'-'-'-... -====- -~''-'-'-... -=====- -~'-'-'.... -====- -~'-'-'-........ -====-
Iii D ' _,,,,,_ ~-- . .. ~,................. ~-- - - _,,,,,._ ~ _,,,,_ ~ _,,,,,,,. ~ 
99.0 -------
I~ Ell ~Iii ~- ~- ~-98.0 
97.0 
1 2 3 4 5 
Days 
Figure 11. Least squares means of temperature values throughout sampling days for calves receiving different ORS formulations. 
A, Commercial; B, Control; C, Added antioxidants; D, Added serum fraction. 
0\ 
0 
41.00 
39.00 
37.00 
35.00 
33.00 
31.00 
29.00 
27.00 
1 2 3 4 5 
Days 
6 
•A 
tmtB 
oC 
iiD 
Figure 12. Least squares means of hematocrit values throughout sampling days for calves receiving different ORS 
formulations. A, Commercial; B, Control; C, Added antioxidants; D, Added serum fraction . . 
0\ ....... 
0.18 ~-------------------
0.16 -1-----------+------------"'F'"---"'I""'--- ---
,,. .... E 0.14 -+-------------i 
........ 
C) E 0.12 .._, 
g 0.1 
~ 0.08 
"-... 
~ 0.06 
(,) 
g 0.04 
0 
0.02 
0 
Day 2 Day 4 
Time (d) 
Day 6 
•A 
~B 
oC 
lilD 
Figure 13. Least squares means of haptoglobin values throughout sampling days for calves receiving different ORS 
formulations. Haptoglobin was analyzed on d 2 prechallenge, d 4, one day post-challenge, and d 6, 3 days post-challenge. 
Commercial; B, Control; C, Added antioxidants; D, Added serum fraction. 
0\ 
N 
63 
DISCUSSION 
In the present study, there were no significant differences in xylose uptake from the 
small intestine between treatment groups. Mean peak xylose concentrations in the current 
study ranged from 23 to 40 mg/dl throughout all sampling times and numerically increased 
following treatments post-challenge, indicating some improvement in gut function. In other 
studies, xylose concentrations in calves with intestinal damage peaks at 45 to 75 mg/dl 
(Holland, 1986; Nappert et al., 1993). In healthy dogs, peak xylose concentrations range 
from 45 to 75 mg/dl. Peak xylose concentrations in dogs suffering from bacterial overgrowth 
in the small intestine are 30 mg/dl (Kirk, 1986). Peak xylose concentrations in the present 
study may indicate the presence of bacterial overgrowth in the small intestine, suggesting 
these calves were infected with multiple pathogens prior to coronavirus challenge. Necropsy 
of one calf revealed the presence of multiple pathogens, including coronavirus, E. coli, 
salmonella and clostridium. Salmonella did not cause significant infection as there was no 
increase in rectal temperature. Another indicator of pathogen overload was a calf mortality 
rate of 24% in this study. Although calves were challenged with coronavirus after arrival, 
they were purchased from sale barns and exposed to many pathogens prior to arrival; 
infection with multiple pathogens may have severely disrupted the absorptive and secretory 
mechanisms of the intestinal tract in ways that were not compatible with the design of the 
study. 
Decreased intestinal absorption and prolonged diarrhea in coronavirus challenged 
calves occurs as cells are sloughed off and replaced with immature cells unable to perform 
normal functions. These immature cells are redirected due to coronaviral infection to 
function only for viral production (Clark, 1993; Holland et al., 1992; Mebus et al., 1975). 
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Insulin-like growth factor-I receptors are present in differentiated villus cells and 
proliferating crypt cells (Morgan et al., 1996). Differentiated villus cells also contain TGF-P 
receptors on their surface (Letterio and Roberts, 1998). Decreases in binding of growth 
factors are usually due to a decrease in number of receptors and not a decrease in receptor 
affinity (Schober et al., 1990). Enterocytes that are undifferentiated due to pathogen 
overload may have decreased numbers of IGF-I and TGF-P receptors. Due to decreased 
receptor concentrations, growth factor binding would also be decreased, thus anticipated 
effects on maturation or proliferation of enterocytes would be decreased as well. 
Additionally, differences between treatments may have been more evident if calves 
were pretreated with concentrated serum protein fraction. Roche et al. (2000) reported that 
effects of viral challenge with Cryptosporidium parvum were ameliorated when colonic cells 
were pre-treated before viral challenge with TGF-Pl versus cells that were treated with TGF-
Pl during or after challenge. Cells pretreated with TGF-Pl were not as permeable as control 
cells and were able to better maintain their mucosa! barrier (Roche et al., 2000). 
Serum protein fraction used in the present study included elevated concentrations of 
IGF-I (1368 ng/ml), TGF-Pl (765 ng/ml), TGF-P2 (9 ng/ml) and IgG (19.7%) fractions. 
Levels of IGF-I found in first-milking colostrum range from 248 to 1850 ng/ml, while TFG-
Pl concentrations range from 12.4 to 42.6 ng/ml (Ginjala and Pakkanen, 1998). The serum 
protein fractions were fed at 1 % of BW, with total concentration of TGF-P 1, for example, fed 
at .2754 mg versus TGF-Pl in colostrum fed at birth at .015336 mg for a calf with an average 
bodyweight of 36 kg. Quigley and Drew (2000) reported calves that were treated orally with 
immunoglobulins had a less severe response to E. coli than calves not treated with 
immunoglobulins. Immunoglobulin G may defend the intestine by preventing the attachment 
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of organisms, reducing their ability to replicate and invade the gut. Treatment with 
immunoglobulins may also affect calves favorably if infection with other enteric pathogens 
occurs (Quigley and Drew, 2000). 
In addition, other researchers have reported that calves fed bovine serum concentrate 
containing concentrated amounts of IgG, IGF-I, and TGF-~1 have reduced diarrhea and gut 
permeability when challenged with cryptosporidium. This may be due to a decreased 
concentration of cryptosporidial organisms able to attach to the small intestinal wall, thereby 
reducing replication of the virus and enterocytes infection (Hunt et al., 2002). 
In the present study, responses to treatments were not significantly different when 
vitamins were supplemented. Once again, calves may not have been able to absorb the 
supplemented vitamins due to extensive epithelial damage caused by infection with multiple 
pathogens. Holland et al. (1992) reported that calves challenged with Cryptosporidium 
parvum have decreased retinol uptake due to increases in the number of undifferentiated 
enterocytes. These immature enterocytes may not be able to synthesize adequate numbers of 
chylomicrons or they may not be able to esterify retinol to the same degree as differentiated 
enterocytes (Holland et al., 1992). 
The optimal ratio of supplementation of vitamins A and E has not yet been 
determined. High dietary vitamin A decreases plasma concentrations of alpha-tocopherol 
(Bieri and Tolliver, 1982; Franklin et al., 1998) as well as liver alpha-tocopherol levels 
(Combs, 1976; Dicks et al., 1959; Eicher et al., 1997; Sklan and Donoghue, 1982). In the 
small intestine, high concentrations of fat-soluble vitamins compete for hydrolysis by brush 
border enzymes (Abawi et al., 1985; Franklin et al., 1998). Once in enterocytes, fat-soluble 
vitamins compete for transfer by fat-soluble carriers (Eicher et al., 1997). In the present 
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study, the ratio of supplemented fat-soluble vitamins may have not allowed for optimal 
absorption and transport of vitamins to tissues under the damaged conditions present in the 
gut. 
Although no significant differences were seen between treatments in the present 
study, many unforeseen factors may have affected these data. Further research needs to be 
conducted to clarify vitamin supplementation ratios as well as effects of growth factor in 
response to controlled damage to intestinal epithelium. 
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CHAPTER3 
EFFECTS OF RUMINAL INFUSION OF ELECTROLYTE SOLUTIONS ON CALF 
PERFORMANCE 
A paper, a portion of which is to be submitted to the Journal of Dairy Science 
S. I. Wawrzyniak, H.D. Tyler, J.D. Quigley, III 
ABSTRACT 
To treat dehydration, diarrheic calves are often ruminally drenched with electrolyte 
solutions. To determine the effects of these solutions on feed intake and average daily gain, 
43 bull calves were ruminally infused with either a commercial electrolyte solution or a 9% 
saline solution at the rate of 10% of body weight per day for three consecutive days. Fifteen 
control calves were sham-infused by inserting the esophageal feeder down the esophagus 
without infusing any fluids. Calf starter and water were offered ad libitum and starter intake 
was recorded daily. Body weights were determined at day -1 (pre-infusion) and day 8 (post-
infusion). Feed intake was significantly lower in calves infused with fluids than in control 
calves (P < .007). Average daily gain was significantly lower in calves infused with fluids 
than in control calves (P < .002). Feed intake (P < .023) and average daily gain (P < .007) 
were decreased in calves infused with electrolytes as compared to calves infused with saline 
solution or control calves. Overall, the infusion of either electrolytes or saline solution into 
the rumen was detrimental to calf performance. 
INTRODUCTION 
Although calves are born as functional nonruminants, microbial populations are 
quickly established and nutritional strategies become dependent on the efficiency of rumen 
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fermentation. When treating calf scours and dehydration using oral rehydration solutions 
(ORS), a common technique is to use an orogastric tube. However, this approach delivers 
ORS directly into the rumen environment. Unfortunately, there is little research on the 
effects of ruminally infusing calves with large amounts of glucose and electrolytes. 
Giduck et al. (1988) reported that infusion of glucose into the rumen of sheep resulted 
in an increase in volatile fatty acids and a decrease in the pH of rumen contents. Although 
rumen contents are well buffered, large quantities of starch added into the rumen overwhelm 
the buffering system, decreasing pH and reducing feed intake (Russell and Hino, 1985). A 
decrease in pH due to the addition of large amounts of starch increases lactic acid-producing 
bacteria, such as Streptococcus bovis, increasing lactate production and further decreasing 
pH. Infusion of large quantities of glucose into the rumen contents also results in extreme 
changes in microbial populations, quickly leading to the death of the animal (Hungate et al., 
1952). 
In addition, ORS contain elevated concentrations of sodium chloride, which may 
induce changes in rumen osmolality. Added amounts of sodium chloride need to be 
evaluated because changes in rumen osmolality decrease voluntary feed consumption when 
osmolality increases over 400 mOsm/kg (Bergen, 1972). The influx of large quantities of 
fluid into the rumen also increases the rate of outflow of organic matter from the rumen, 
decreasing efficiency of microbial digestion (Godwin and Williams, 1986). 
There are no published data on changes in feed intake of calves due to ruminal 
infusion of commercial oral rehydration solutions (ORS) containing high concentrations of 
glucose and electrolytes. The purpose of this study was to evaluate the effects of infusing 
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commercial ORS directly into the rumen on feed intake and body weight gain of young 
calves. 
MATERIALS AND METHODS 
Forty three male Holstein calves between 8 and 10 weeks were housed in individual 
plastic hutches. Calves were offered water and grain starter ad libitum and feed intake was 
monitored starting -3 days before the start of the treatments through 7 days after initiation of 
treatments. Calves were weighed on day 1 and day 10. 
Treatments 
For calves in the control group (n=15) orogastric tubes were inserted for 5 seconds 
and withdrawn. Calves in the saline group (n=15) were infused with a standard 9% NaCl 
solution and calves in the electrolyte group (n=13) were infused with a commercial 
electrolyte solution. All calves in the latter two groups were infused with their respective 
treatments at the rate of 10% of BW for 3 days. For the first treatment day, they received 
treatments at the rate of 10% of BW in the morning only, the second treatment day they 
received treatments at the rate of 5% of BW in the morning and the rate of 5% of BW at 
night and the third treatment day they received treatments at the rate of 5% of BW in the 
morning and the rate of 5% of BW at night. 
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Table 5. Ingredient composition of commercial oral rehydration solution1 
Ingredient 
Sodium 
Chloride 
Potassium 
Dextrose 
Glycine 
Sodium Bicarbonate 
Citric Acid 
mmol/L 
145.87 
117.01 
5.11 
249.83 
1.89 
27.03 
3.69 
1 Merrick's, Inc. Blue Ribbon Electrolyte Formula, Union Center, WI 
Statistical analysis 
Analysis of variance was performed using the mixed procedures of SAS 8.1 (SAS, 
1999) using a model for a completely randomized design. Mean values of feed intake from 
days -1, -2 and -3 pre-infusion were used as a covariate in the model. Calf weight from day -
1 pre-infusion was also used as a covariate in the model. The error term in the model was 
calf within treatment. Orthogonal contrasts were used to compare differences between calves 
sham-infused and calves infused with saline, calves sham-infused and calves infused with 
ORS and calves infused with saline and calves infused with ORS. Treatment means were 
compared using the method of least squares means in the general linear model procedure of 
SAS 8.1 (SAS, 1999). The error term in the model was calf within treatment. 
RESULTS 
Least squares means for feed intake for all groups are shown in Figure 14. Calves 
infused with fluids had lower feed intake than control calves (P < 0.007) during infusion and 
post-infusion. Calves infused with electrolytes had lower feed intake than calves infused 
with saline or control calves (P < 0.023) during infusion and post-infusion. 
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Least squares means for average daily gain for all groups are shown in Figure 15. 
Calves infused with fluids had lower average daily gain than control calves during infusion 
and post-infusion (P < 0.002). Calves infused with electrolytes had lower average daily gain 
than calves infused with saline or control calves during infusion and post-infusion (P < 
0.007). 
Results for feed efficiency for all groups are shown in Figure 16. Calves infused with 
fluids had higher feed to gain ratio than control calves, indicating lower feed efficiency for 
these calves than for calves not infused with fluids during infusion and post-infusion (P < 
0.011). Calves infused with electrolytes had higher feed to gain ratio than calves infused 
with saline or control calves, indicating lower feed efficiency during infusion and post-
infusion (P < 0.0024). However, feed efficiency for calves infused with saline was not 
significantly different from feed efficiency for control calves during infusion and post-
infusion (P > 0.05). 
DISCUSSION 
Infusion of large amounts of fermentable carbohydrates into the rumen of an adult 
animal increases lactic acid production and decreases rumen pH (Eadie et al., 1967; Giduck 
et al., 1988; Irwin et al., 1972). In the present trial, calves infused with fluids into the rumen 
had lower feed intake than control calves that were sham infused. Feed intake was even 
further decreased in calves infused with electrolytes compared to calves infused with saline 
or control calves. 
In the present study, calves infused with a standard electrolyte solution containing 
2000 mmol/L glucose received a large amount of highly fermentable carbohydrate in a single 
dose. It is well documented that abrupt additions of large amounts of concentrates to diets of 
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ruminants results in acidosis. Giduck et al. (1988) reported that infusing whethers with 40% 
(w/v) glucose resulted in a drop in rumen pH, which then normalized within two hours. This 
decrease in pH is due to an increase in the production of lactic acid, which accumulates when 
its rate of production exceeds its rate of metabolism (Giduck et al., 1988; Slyter, 1976). This 
causes a shift in microbial populations in the rumen, inhibiting microbial cellulose-degrading 
activity and decreasing feed intake (Irwin et al., 1972). An increase in concentrations of 
starch-digesting microbes, as well as high amounts of concentrates fed, can lead to sub-acute 
or acute acidosis. Acidosis, defined as a digestive disturbance, leads to reduced performance 
of the animal (Eadie et al., 1967; Slyter, 1976). 
In the present study, average daily gain decreased in calves that were infused with 
fluids as compared to control calves, possibly due to sub-acute acidosis. This decrease in 
weight gain may be a result of a lower digestibility of feed in conjunction with a decreased 
feed intake. In sheep, ruminal infusion of 30 g NaCl per day resulted in an increased osmotic 
pressure, decreasing dry matter digestibility, nitrogen digestibility, and rumen ammonia 
(Bergen, 1972; Godwin and Williams, 1986). 
In conclusion, infusing ORS into the rumen of calves may induce adverse effects on 
calf performance, even in healthy calves. Average daily gain was reduced in calves infused 
with fluids as a result of decreased feed intake and reduced feed efficiency. Fluid infusion in 
this trial may have negatively affected rumen microbial populations and increased production 
of acids, adversely affecting rumen environment. Further investigation into both short and 
long term effects of ruminal infusion of fluids in young calves is warranted. 
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CHAPTER4 
GENERAL CONCLUSIONS 
This research represents an effort to further the knowledge and understanding of oral 
rehydration solutions and their effects on neonatal calves. Neonatal calf diarrhea is a major 
cause of death and economic loss from calves in the dairy industry (Constable et al., 1996; 
Torres-Medina et al., 1985). Once a calf develops diarrhea, it is often treated with an oral 
rehydration solution, to increase hydration and replace extracellular fluid volume (Clark, 
1993; Groutides and Michell, 1990). An effective oral rehydration solution should reduce 
dehydration, metabolic acidosis and hyperkalaemia (Groutides and Michell, 1990). 
Coronavirus is one of the most common pathogens that causes calf scours, along with 
cryptosporidium and rotavirus (McDonough et al., 1994). Anywhere from 15 to 70% of 
diarrheal outbreaks in calves may be due to coronavirus (Crouch et al., 1985). A viral 
challenge may cause the development of nutritional deficiencies and, in tum, accentuate the 
effects of the disease by suppressing immune response and resistance (Wang et al., 1994 ). 
Calves challenged with viral disease benefit from the supplementation of vitamins and serum 
proteins (Arthington et al., 2002; Reddy et al., 1985). 
In the current study supplementation of vitamins or serum proteins into oral 
rehydration solutions had no effect on return of intestinal function or performance parameters 
in neonatal calves. Young pigs show an improvement in small intestinal absorption when fed 
a serum fraction during challenge with disease-causing pathogens (Cain and Zimmerman, 
1997). During E. coli challenge, oral administration of immunoglobulins protects the calf 
against harmful effects (Quigley and Drew, 2000) and may also protect during infection with 
bovine coronavirus. Tight junctions are maintained in the small intestine with vitamin A 
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supplementation in infants born to HIV-infected women, decreasing intestinal permeability 
and maintaining membrane integrity (Burton et al., 1983; Combs and Gerald, 1992; Filteau et 
al., 2001; Gonzalez et al., 2001). 
Although no significant differences were seen between treatments in the present 
study, many unforeseen factors may have affected these results. Further research needs to be 
conducted to clarify vitamin supplementation ratios as well as effects of growth factor in 
damaged intestinal epithelium. 
When infusing calves with either an oral rehydration solution or saline solution into 
the rumen, calf performance is decreased and this practice should be avoided if possible. 
Although esophageal feeding may be a necessary treatment in extreme cases, all calves still 
capable of suckling should be bottle-fed to avoid a decline in rumen function that may 
adversely affect feed intake and average daily gain. 
In conclusion, formulations of oral rehydration solutions need to be developed that 
not only correct acid-base balance in the body but repair gut damage in infected calves. 
These oral rehydration solution formulations need to have less adverse effects when 
ruminally infused as not to further deteriorate the performance and health of infected calves. 
LITERATURE CITED 
Arthington, J. D., C. A. Jaynes, H. D. Tyler, S. Kapil and I. Quigley, J. D. 2002. The use 
of bovine serum protein as an oral support therapy following coronavirus 
challenge in calves. J. Dairy Sci. 85:1249-1254. 
Burton, G. W., A. Joyce and K. U. Ingold. 1983. Is vitamin Ethe only lipid-soluble, chain-
breaking antioxidant in human blood plasma and erythrocyte membranes? Arch. 
Biochem. Biophys. 221:281-290. 
Cain, C. M. and D.R. Zimmerman. 1997. Effect of spray-dried plasma (SDP) on fecal 
shedding of hemolytic Escherichia coli (HEC) and rotavirus by pigs in a segregated 
early weaned (SEW) environment. J. Anim. Sci. 75(Suppl. 1):61. 
82 
Clark, M.A. 1993. Bovine coronavirus. Br. Vet. J. 149:51-70. 
Combs, J. and F. Gerald. 1992. Vitamin A. The vitamins: fundamental aspects in nutrition 
and health. Academic Press, Inc., San Diego. 
Constable, P. D., H. M. Gohar, D. E. Morin and J. C. Thurmon. 1996. Use of hypertonic 
saline-dextran solution to resuscitate hypovolemic calves with diarrhea. Am. J. Vet. 
Res. 57 :97-104. 
Crouch, C. F., H.B. Ohmann, T. C. Watts and L.A. Babiuk. 1985. Chronic shedding of 
bovine enteric coronavirus antigen-antibody complexes by clinically normal cows. J. 
Gen. Virol. 66:1489-1500. 
Filteau, S. M., N. C. Rollins, A. Coutsoudis, K. R. Sullivan, J. F. Willumsen and A. M. 
Tomkins. 2001. The effect of antenatal vitamin A and beta-carotene supplementation 
on gut integrity of infants of HIV-infected South African women. J. Pediatr. 
Gastroenterol. Nutr. 32:464-470. 
Gonzalez, R., F. Sanchez de Medina, J. Galvez, M. E. Rodriguez-Cabezas, J. Duarte and A. 
Zarzuelo. 2001. Dietary vitamin E supplementation protects the rat large intestine 
from experimental inflammation. Int. J. Vitam. Nutr. Res. 71:243-250. 
Groutides, C. P. and A. R. Michell. 1990. Changes in plasma composition in calves surviving 
or dying from diarrhoea. Br. Vet. J. 146:205-210. 
McDonough, S. P., C. L. Stull and B. I. Osburn. 1994. Enteric pathogens in intensively 
reared veal calves. Am. J. Vet. Res. 55:1516-1520. 
Quigley, I., J. D. and M. D. Drew. 2000. Effects of oral antibiotics or bovine plasma on 
survival, health and growth in dairy calves challenged with Escherichia coli. Food 
Agric. Immunol. 12:311-318. 
Reddy, P. G., J. L. Morrill, R. A. Frey, M. B. Morrill, H. C. Minocha, S. J. Galitzer and A. D. 
Dayton. 1985. Effects of supplemental vitamin Eon the performance and metabolic 
profiles of dairy calves. J. Dairy Sci. 68:2259-2266. 
Torres-Medina, A., D. H. Schlafer and C. A. Mebus. 1985. Rotaviral and coronaviral 
diarrhea. Vet. Clin. North Am. Food Anim. Pract. 1:471-493. 
Wang, Y., B. Liang and R.R. Watson. 1994. Suppression of tissue levels of vitamin A, E, 
zinc and copper in murine AIDS. Nut. Res. 14:1031-1041. 
83 
APPENDIX A 
XYLOSE AND HAPTOGLOBIN METHODOLOGY 
Protocol for assay of haptoglobin concentrations 
1. Label S tubes Cl, C2, C3, C4, and CS. These correspond to haptoglobin standards 2, 
1, O.S, 0.2S and 0 mg/ml. 
2. Cl: Add SO µL of stock (volume calibrator) 
3. C2: Add SO µL of stock (volume calibrator) and SO µL of volume diluent 
4. C3: Add SO µL of C2 and SO µL of volume diluent 
S. C4: Add SO µL of C3 and SO µL of volume diluent 
6. CS: Add SO µL of volume diluent 
7. Reagent 1: Premix equal volumes of hemoglobin and hemoglobin diluent (half of 
each) 
8. Reagent 2: Mix 7 .2 ml chromogen and 4.0 ml substrate 
9. Transfer 7.S µL of Cl, C2, C3, C4, and CS to plate 
10. Transfer 7.S µL of calf specimens, in duplicate, to plate 
11. Add 100 µL of Reagent 1 to each microwell with multi-channel pipette 
12. Tap gently to mix 
13. Add 140 µL of Reagent 2 to each microwell with multi-channel pipette 
14. Incubate for S minutes at room temperature 
lS. Read IMMEDIATELY at 630 nm. 
16. Generate a curve. 
Protocol for assay of xylose concentrations 
1. Place SO µL of serum in 16 x lOOmm disposable test tube 
2. Add S mL of phloroglucinol color reagent (consisting of O.S g phloroglucinol, 100 
mL glacial acetic acid, and 10 mL concentrated hydrochloric acid) 
3. Heat all tubes exactly 4 min at lOO°C, and cool to room temperature in cool water 
4. Adjust spectrophotometer to zero absorbance with a reagent blank containing water 
(SOµL) and phloroglucinol reagent (S.O mL) before reading standard solutions, and 
with a serum blank (SO µL of xylose-free serum plus S.O mL of phloroglucinol 
reagent) before reading absorbance of serum samples. These "blank" solutions are 
heated and cooled along with the other solutions before reading absorbance. A single 
serum blank is used for the entire analytical run. 
S. After mixing each serum sample, read absorbance at SS4 nm. 
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Appendix B 
ADDITIONAL REVIEW INFORMATION OF SPECIFIC VITAMINS 
Vitamin A 
Vitamin A includes many compounds that display retinoid activity. These are 
hydrophobic and insoluble in aqueous environments, such as intestinal lumen, plasma, 
interstitial fluid, and cytosol, and soluble in alcohols and fats. Although vitamin A is most 
widely known for its function in visual processes, it has many other systemic functions in the 
body (Combs and Gerald, 1992). 
Clinical signs of vitamin A deficiency consist of keratinization of epithelial 
membranes leading to rough, scaly skin (Combs and Gerald, 1992; Rojanapo et al., 1980; 
Uni et al., 2000; Uni et al., 1998). Other clinical signs include xerophthalmia, weight loss 
(Combs and Gerald, 1992; Zile et al., 1977) and disturbances in the central nervous system 
(Zile et al., 1977). These clinical symptoms may be caused by lesions and morphological 
changes at the cellular level (West et al., 1992; Zile et al., 1977). 
Retinol is secreted from enterocytes into hydrophobic cores of chylomicron particles 
(Combs and Gerald, 1992). There, retinol is transported to the liver as retinyl esters, attached 
to fatty acids that were present during absorption (Leeson and Summers, 2001). These 
chylomicra are hydrolyzed, causing them to become chylomicron remnants, retain all the 
retinyl esters and, as a result, have a higher concentration of vitamin A than chylomicra 
themselves. The retinyl esters are transported through the lymphatic system and enter the 
plasma compartment through the thoracic duct (Combs and Gerald, 1992). Once at the liver, 
chylomicron remnants are taken up by parenchymal cells through receptor-mediated 
endocytosis (Combs and Gerald, 1992; Matsuura et al., 1997). 
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When chylomicron remnants enter the liver they are degraded by lysosomal enzymes 
and retinol is re-esterified with long chain fatty acids to retinyl esters in the parenchymal 
cells (Combs and Gerald, 1992; Matsuura et al., 1997). This re-esterification in the liver is 
accomplished by retinol binding to cellular retinol-binding protein type II [CRBP(II)] and 
being catalyzed by lecithin:retinol acyl-transferase (LRAT) (Combs and Gerald, 1992; 
MacDonald and Ong, 1988). When retinal binds to CRBP(II), forming retinal-CRBP(II) 
complex, it is reduced by retinal reductase to retinol. When retinol binds to CRBP(II) 
forming retinol-CRBP(II) complex, it is reduced by LRAT to retinyl esters (Herr et al., 
1993). This binding protein serves to increase the efficiency of vitamin A absorption by 
shuttling retinoids to their respective enzymes (Herr et al., 1993; MacDonald and Ong, 
1988). 
Retinyl esters are transferred to stellate cells where they are stored; thus, the liver 
contains more than 90% of the total vitamin A stores in the body (Combs and Gerald, 1992; 
Matsuura et al., 1997). Stellate cells are nonparenchymal cells that are in the perisinusoidal 
space and include fat-storing cells, Ito cells, and lipocytes (Blomhoff et al., 1982; Matsuura 
et al., 1997). 
Retinyl ester hydrolase mobilizes retinyl esters from hepatic cells (Combs and Gerald, 
1992). Once mobilized in the liver, plasma retinol binding protein (RBP) transports retinol to 
peripheral tissues (Alvarez et al., 1995; Combs and Gerald, 1992; Nonnecke et al., 2001). 
Retinol binding proteins are secreted from the liver attached to retinol, forming complexes 
that attach to transthyretin (formerly known as prealbumin) in the plasma. This attachment 
to transthyretin decreases the chances of retinol being filtered out and catabolized in the 
kidney (Alvarez et al., 1995; Combs and Gerald, 1992; Nonnecke et al., 2001). 
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Secretion of this transporter is regulated by several factors, including estrogen levels, 
vitamin A intake, vitamin A hepatic stores, and zinc status (Combs and Gerald, 1992; 
Nonnecke et al., 2001). If animals become vitamin A deficient, retinol-binding protein 
(RBP) production is reduced, decreasing levels of retinol in the bloodstream (Combs and 
Gerald, 1992). 
Once retinol enters target cells, it is bound by cellular retinol-binding protein (CRBP), 
which transports retinol within and between cells and allows the hydrophobic moiety to be 
presented to enzymes (Combs and Gerald, 1992). 
Storage 
There is an initial rapid uptake of retinyl esters from blood into parenchymal cells of 
the liver. Some of the retinyl esters are directed back through the blood to other 
nonparenchymal cells that include adipocytes, lipocytes, perisinusoidal stellate cells, Ito 
cells, and vitamin-A storing cells (Blomhoff et al., 1982). 
Studies in rats show stores of up to 300 nmol of retinol in extravascular and 
extrahepatic tissues when liver retinol is depleted (Green and Green, 1994). This is 
confirmed by the presence of LRAT in nonhepatic tissues, which can convert retinol to 
retinyl esters for storage in extrahepatic tissues, such as the intestinal wall (Herr et al., 1993). 
Cellular retinol binding protein is also found in the intestinal wall and serves as a carrier of 
retinol and retinal for LRAT (Herr et al., 1993). This may help explain why no differences 
are seen in some studies comparing vitamin A deficient and vitamin A sufficient groups, if 
stores of retinol are present in extrahepatic tissues (Warden et al., 1997). Deficient animals 
tend to conserve their extrahepatic stores, using them only when hepatic stores are low 
(Green and Green, 1994). 
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When there is a stressor introduced, such as Newcastle disease virus in chickens, 
plasma concentrations of retinal decrease dramatically not only because of an impairment of 
absorption from the intestine, but also because of an increased rate of utilization by the 
tissues (West et al., 1992). 
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Vitamin E 
Vitamin E is the primary antioxidant capable of breaking the chain of lipid 
peroxidation in plasma and red blood cells (Burton et al., 1983). During transport of 
compounds that are easily oxidized, such as polyunsaturated fatty acids (PUFAs) or 
cholesterol, vitamin E inhibits oxidation, keeping fatty acids viable (Traber and Kayden, 
1984). To effectively reduce radicals, vitamin E also maintains the glutathione antioxidant 
system. This system is not limited to lipid membranes and therefore allows alpha-tocopherol 
to reduce radicals in aqueous portions of cells (Gonzalez et al., 2001). 
A single free radical in one PUF A can begin a chain reaction affecting other PUF As 
until the integrity of the entire membrane is compromised, as seen during the oxidation of 
low-density lipoproteins (LDL) (Combs and Gerald, 1992; Sato et al., 1990). 
By donating a hydrogen off the phenol group located on the phytic tail of alpha-
tocopherol, unpaired electrons are stabilized and peroxidative damage is terminated. 
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This results in the production of alpha-tocopheroxyl, a radical that is stable and much safer 
than membrane free radicals. Donation of a second hydrogen from alpha-tocopheroxyl will 
form alpha-tocopherylquinone. This second step is irreversible causing this vitamin E 
metabolite to be excreted in urine or feces (Combs and Gerald, 1992). 
When alpha-tocopherol-rich lipoproteins are incubated with other lipoproteins that 
are devoid of alpha-tocopherol, there is transfer and equilibration of the vitamin (Massey, 
1984 ). However, Clevidence and Lehmann ( 1989) reported that the distribution of alpha-
tocopherol among lipoproteins was not solely based on nonspecific diffusion. High-density 
lipoproteins (HDL) have a high affinity for alpha-tocopherol, indicating that diffusion of 
alpha-tocopherol between lipoproteins may be regulated (Clevidence and Lehmann, 1989). 
Using affinity chromatography, Clevidence and Lehmann (1989) showed that most alpha-
tocopherol that is bound to HDL remained bound even when low-density lipoprotein (LDL) 
concentration was increased to ten times that of HDL concentration. This may provide an 
advantage for tissues that have a high utilization and storage requirement for alpha-
tocopherol and also have a high affinity to HDL. Although alpha-tocopherol reaches many 
tissues through LDL receptor pathways, other tissues receive alpha-tocopherol because of 
their affinity for HDL (Clevidence and Lehmann, 1989). Certain peripheral tissues may have 
a high affinity for HDL because of its size and ability to move easily from plasma to tissues 
(Clevidence and Lehmann, 1989). 
Once alpha-tocopherol is delivered to the liver, human plasma lipid transfer protein 
was found to accelerate the transfer between lipoprotein classes, especially HDL and cell 
membranes (Kostner et al., 1995). About 90% of alpha-tocopherol is secreted from the liver 
in VLDL; when VLDL secretion is inhibited, plasma alpha-tocopherol is decreased 
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(Bjomeboe et al., 1987; Cohn et al., 1988). Less than 1 % of alpha-tocopherol is secreted in 
HDL from hepatic stores (Bjomeboe et al., 1987). Because LDL are precursors to VLDL, 
the amount of alpha-tocopherol found in VLDL is directly related to amounts found in LDL 
(Cohn et al., 1988). 
Although cellular uptake of vitamin Eis not well understood, lipoprotein lipase may 
be involved (Combs and Gerald, 1992; Traber and Kayden, 1984; Traber et al., 1985). 
Traber et al. (1985) reported that addition of lipoprotein lipase to chylomicrons in cell 
cultures hydrolyzed triglycerides and transferred both fatty acids and alpha-tocopherol into 
the cells. When lipoprotein lipase was not present in chylomicrons, cellular tocopherol did 
not increase, indicating that lipoprotein lipase must bind to cell membranes in order to 
transfer tocopherol to cells from lipid droplets. Research conducted with human subjects 
suffering from disorders involving low levels of lipoprotein lipase suggests that lipoprotein 
lipase is involved in transferring dietary tocopherol to cells (Traber et al., 1985). 
Another method of delivery of alpha-tocopherol to cells may be through LDL binding 
to high affinity receptors (Traber and Kayden, 1984; Traber et al., 1985). The presence of 
LDL receptors causes an increased uptake of LDL into cells increasing cellular alpha-
tocopherol concentrations when compared to cells that do not contain LDL receptors (Traber 
and Kayden, 1984). Although both pathways are important, the pathway utilizing lipoprotein 
lipase seems to be 10-fold more effective than the LDL pathway (Traber et al., 1985). 
Once in cells, there are tocopherol-binding proteins (TBPs) which then serve to 
transport alpha-tocopherol within the cell. Alpha-tocopherol also binds to retinal-binding 
proteins for transport, although it is displaced by the presence of retinal (Combs and Gerald, 
1992). 
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Ninety percent of alpha-tocopherol is stored in skeletal muscle, liver and adipose 
tissue. Adrenal glands have the highest amount of alpha-tocopherol per gram of tissue due to 
their high affinity for HDL (Bjomeboe et al., 1986). In the liver, 25% of total alpha-
tocopherol stores are found in nonparenchymal cells (as compared to 44% of hepatic 
retinoids) (Bjomeboe et al., 1986; Blomhoff et al., 1982). 
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Interactions Between Vitamins A and E 
Many researchers have reported an interaction between vitamin A and vitamin E in 
vivo. High dietary vitamin A decreases plasma alpha-tocopherol (Bieri and Tolliver, 1982; 
Franklin et al., 1998) as well as liver alpha-tocopherol levels (Combs, 1976; Dicks et al., 
1959; Eicher et al., 1997; Sklan and Donoghue, 1982). Conversely, if there is a deficiency in 
retinol, this increases concentrations of hepatic alpha-tocopherol levels (Roels et al., 1964). 
Plasma vitamin A concentrations are also affected by the level of intake of vitamin E. 
Plasma vitamin A concentrations are decreased when dietary vitamin E intakes are high or 
moderate (Abawi et al., 1985; Eicher et al., 1997; Napoli et al., 1984). However, although 
plasma vitamin A concentrations are decreased, hepatic vitamin A stores are increased 
(Combs and Gerald, 1992; Napoli et al., 1984; Roels et al., 1964). 
In the liver, retinyl ester hydrolase releases vitamin A from storage in the stellate 
cells (Combs and Gerald, 1992). This enzyme hydrolyzes vitamin E and K as well, and 
when they are present in higher concentrations, less hepatic retinol may be released due to 
competitive inhibition (Combs and Gerald, 1992). Napoli et al. (1984) reported that high 
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dietary vitamin E may also decrease retinol stores by altering retinyl palmitate hydrolase 
activity. 
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Vitamin C 
Ascorbic acid is a water-soluble antioxidant vitamin capable of easily diffusing into 
blood vessels and extravascular fluid (Black and Hidiroglou, 1996). Because of this, 
ascorbic acid is involved in electron transfer reactions in every tissue throughout the body. 
Ascorbic acid has a role in collagen synthesis due to its ability to hydroxylate two 
amino acids, proline and lysine (McDowell, 1989). Ascorbic acid plays an important role in 
reproductive function because there are high levels of collagen synthesis in corpus luteum 
and ovarian stroma. Porcine corpus luteum, when fully developed, contains the second 
highest concentration of ascorbic acid in the body. As the corpus luteum develops, 
concentrations of ascorbic acid steadily increase within the corpus luteum. As the corpus 
luteum regresses, ascorbic acid concentrations decrease as well. The ratio of 
dehydroascorbate to total ascorbate are high when the corpus luteum is forming indicating 
significant collagen synthesis and increased capacity of antioxidant function (Petroff et al., 
1997). 
Ascorbic acid also modifies bone mineral content by hydroxylating proline and 
lysine, increasing collagen in bone. Animals deficient in vitamin C may suffer bone 
abnormalities due to lack of hydroxylation of collagen residues resulting in decreased 
stability of bone matrix. This alters cell function and increases mineralization, affecting the 
growth plate in bone. When vitamin C is added to chondrocyte cultures, the chondrocytes 
secrete different collagens and upregulate alkaline phosphatase, increasing cellular 
maturation of bone and cartilage (Shapiro et al., 1991 ). 
Animals that are deficient in vitamin C have decreased uptake of vitamin B 12 
through the intestinal wall, which may contribute to the development of anemia in scorbutic 
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animals (Dulloo et al., 1981). Ascorbic acid increases the uptake of selenium in the gut. 
This increases glutathione peroxidase function, thereby decreasing lipid peroxidation in 
chicken capillary cell walls (Combs and Pesti, 1976). 
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Interactions Between Vitamins C and E 
The conversion from alpha-tocopheroxyl back to alpha-tocopherol requires a 
reducing agent such as ascorbic acid (Combs and Gerald, 1992; Doba et al., 1985; Ginter et 
al., 1982; Niki, 1991; Sato et al., 1990). Some research indicates that in vivo recycling of 
vitamin Eby vitamin C may not happen due to compartmentalization of vitamin C in the 
aqueous cytosol and tocopheroxyl in lipid membranes (Combs and Gerald, 1992; Sato et al., 
1990). Others reported that, although there is compartmentalization, alpha-tocopheroxyl 
radicals are available to vitamin C due to exposure of the polar alpha-tocopherol head at the 
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membrane surface (Doba et al., 1985; Niki, 1991; Sato et al., 1990). Niki (1991) showed 
that the efficiency with which ascorbic acid reduces tocopherol decreases when the 
tocopheroxyl radical is located deeper in the membrane. 
The problem of compartmentalization may also be overcome by the glutathione 
peroxidase system which actively shuttles electrons from the soluble phase of cells to 
radicals in membranes (Chen and Chang, 1978; Combs and Gerald, 1992). Vitamin C favors 
the glutathione peroxidase system, which interacts synergistically with alpha-tocopherol, 
thereby sparing alpha-tocopherol in the process (Chen and Chang, 1978). 
When vitamin C regenerates alpha-tocopherol, a vitamin C radical is formed (Doba et 
al., 1985; Ginter et al., 1982; Packer et al., 1979; Sato et al., 1990). When vitamin C was 
added to diets of animals fed low dietary alpha-tocopherol, tissue antioxidant status was 
improved by increasing mitochondrial respiration, resulting in a decrease in liver 
peroxidation (Chen and Chang, 1978). 
Vitamin C deficient guinea pigs tend to have low concentrations of alpha-tocopherol 
resulting from an increased susceptibility of vitamin E to oxidation without the presence of 
the reducing ability of vitamin C (Hruba et al., 1982). Vitamin C deficient animals have low 
concentrations of alpha-tocopherol in liver, lungs and kidneys, due to alpha-tocopherol 
replacing the missing ascorbic acid in some oxidation-reduction processes (Hruba et al., 
1982). 
Enriching a vitamin E deficient diet with vitamin C results in less lipid peroxidation 
(Doba et al., 1985; Ginter et al., 1982; Sato et al., 1990). The addition of vitamin C into 
aqueous parts of a mixture in the process of LDL oxidation decreases alpha-tocopherol 
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utilization and oxygen uptake, thereby increasing concentrations of vitamin E (Sato et al., 
1990). 
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